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SUMMARY 
Traumatic brain injury (TBI) is currently a leading cause of death and disability in 
individuals under the age of 45 years in developed nations. Accordingly, the incidence of 
, TBI is high in people during the most productive years of their life and often results in 
prolonged or life-long impairments in cognition and personality. In this regard, diffuse 
axonal injury (DAI) is proposed to be a major cause of on-going disability following mild 
to severe forms of brain injury. As DAI represents an evolving form of axonopathy, taking 
hours to days to develop, there is a substantial 'therapeutic window' for possible 
interventions. This thesis introduces a novel in vitro method for causing mild-moderate 
transient axonal shear strain that leads. over 2-3 days, to secondary DAI-like axotomy. This 
injury method provides important mechanistic insights into the underlying cause of DAI, 
presenting also an ideal platform for investigating new therapeutic approaches. 
Altered membrane permeability, particularly in regard to disrupted calcium homeostasis, 
and the gradual degradation of the cytoskeleton resulting in axon swellings, are important 
pathological features of DAI. It has long been proposed that altered membrane 
permeability, due to mechanical strain, is an initiator for secondary axotomy. This thesis 
demonstrates, using cell-impermeant tracers, that altered membrane permeability is not an 
immediate consequence of injury, rather it is associated with the delayed degradation of the 
axon cytoskeleton. Conversely, this thesis demonstrates, using calcium imaging techniques, 
immediate increases in intracellular calcium, principally due to release of calcium from 
intracellular stores. Immunocytochemical analysis further demonstrated the calcium-
modulated release of pro-apoptotic proteins, which are also associated with the degradation 
of the cytoskeleton, at later time-points. The pharmacological inhibition of the calcium-
activated phosphatase, calcineurin, attenuated cytoskeletal damage and delayed secondary 
axotomy. These results suggest the release of calcium from intracellular stores, at the time 
of injury, initiates the post-injury sequelae, which results in cytoskeletal degradation and 
secondary axotomy due to calcium activated proteases and phosphatases. 
v 
Altered ubiquitin proteasome system (UPS) activity is proposed to play an important role in 
the secondary degeneration of neurons following injury and in many neurodegenerative 
disorders. Accordingly, the pharmacological inhibition of the UPS is proposed to attenuate 
axonal degeneration. This thesis illustrates that UPS activity plays an important role in 
delaying secondary axotomy, indicated by an accelerated progression to secondary 
axotomy following inhibition of the UPS. Furthermore, mild to moderate mechanical injury 
induces neurite sprouting. These highly dynamic neurites contained growth associated 
proteins, however, lacked growth guidance structures, which may contribute to undirected 
and abnormal synaptic connections that underlie epileptiform activity following human 
cases of DAI. 
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INTRODUCTION 
1.1 TRAUMATIC BRAIN INJURY 
Traumatic brain injury (TBI) is currently one of the most common causes of death and 
disability in individuals under the age of 45 years in developing nations (McDermott et al., 
2004). Accordingly, the incidence of TBI is high in people during the most productive 
years of their lives and regularly leads to prolonged or life-long impairments in cognition 
and personality. Mechanical trauma and/or rapid acceleration/deceleration involving the 
head often results in widespread axonal damage, or diffuse axonal injury (DAI) in which 
neural circuitry is disrupted or lost throughout the brain. Damage to the brain following 
injury is further exacerbated due to the poor regenerative capacity of mature neurons. Thus, 
even the loss of only a few neurons may cause permanent disruption to neural connections 
and widespread dysfunction of the circuits into which they integrate. 
Head trauma commonly results in both immediate (primary) and delayed secondary 
damage. In the majority of head injury cases, secondary DAI damage is proposed to be a 
significant contributor to on-going disability (Buki and Povlishock, 2006). As reviewed 
below, neurons undergo a structured series of alterations following DAI. This response 
involves a number of intrinsic and extrinsic pathways, which may result in either delayed 
axotomy, or attempted regeneration of the damaged neuron. Alterations to the axonal 
cytoskeletal proteins, particularly microtubules and the intermediate filament protein 
subclass known as the neurofilament triplet proteins, play a pivotal role in the post-injury 
sequelae. There is still a fundamental lack of information about the underlying cellular and 
molecular mechanisms that lead to delayed axotomy, mainly due to the inadequacies of 
previous axonal injury models. 
As DAI represents an evolving form of axonopathy that takes hours to days to develop 
there is a substantial 'therapeutic window' for possible interventions targeted at either 
impeding the cellular changes that lead to secondary axotomy or promoting possible 
regeneration. Historically, most interventions following DAI have focused on inhibiting the 
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detrimental cascades activated after trauma, as regeneration in the mature mammalian brain 
was believed to be impossible. Current therapeutic interventions have failed to translate 
into a positive outcome in human cases of brain injury and it is increasingly clear that 
further interventions need to be assessed in models of axonal injury that induce the full 
spectrum of pathological features. 
It is now clear that the mammalian brain retains remarkable plasticity well into adulthood. 
As detailed in the literature review below, in mature neurons, regenerative attempts may 
manifest as the elaboration of new axons or sprouts from pre-existing neurons. This 
regenerative capacity has been well-documented following axon transection and compared 
to the growth response during development. The regenerative response of diffusely injured 
axons remains unknown although, in the majority of head injury cases, axons are not 
immediately severed. Whether injury-induced axonal sprouting results in the restoration of 
neural connectivity and function remains contentious, however, it is agreed that if the repair 
process is purely reliant on endogenous capacity, regeneration is limited. 
This thesis will, therefore, seek to investigate the potential of a novel in vitro model of 
mild/moderate axonal injury to replicate the progressive series of pathological features 
observed in the majority of clinical TBI cases. This will illustrate the long-term neuronal 
response to injury, particularly in relation to the role of the cytoskeleton and the possible 
cellular degenerative and regenerative pathways. Additionally, this information will 
provide insight into possible therapeutic strategies for the treatment of TBI. 
1.2 PRIMARY AND SECONDARY BRAIN DAMAGE 
Brain trauma may result in tissue deformation at the moment of injury due to mechanical 
forces (referred to as primary brain damage). This deformat~on may directly damage blood 
vessels, axons, neurons and glia, initiating dynamic and evolving processes resulting in 
complex cellular, inflammatory, neurochemical and metabolic alterations (Blumbergs et al., 
1989; Finnie and Blumbergs, 2002). Secondary brain damage arises from complications 
following primary brain damage. These include ischemic and hypoxic damage concomitant 
2 
with cerebral swelling, the consequences of raised intracranial pressure, hydrocephalus and 
infection (Blumbergs et al., 1989). Inflammatory and cytotoxic mechanisms of injury are 
often the product of ischemia, which is considered to be one of the largest contributors to 
secondary brain damage. Post-mortem studies of victims of TBI indicate that cerebral 
ischemia is a common consequence (Egeler-Peerdeman, 1998). Hypoxemia and 
hypotension are also common clinical findings in patients with TBI (Chesnut et al., 1993). 
Cerebral hypotension is one of the principal predictors of a poor outcome after 'J'BI 
(Chesnut et al., 2000) and it has been documented that a single episode of hypotension can 
be linked to a 150% increase in mortality rate (Chesnut et al., 1993; Statler et al., 2001). 
The type and severity of pathological features following TBI is dependant on the 
biomechanics of head trauma. 
1.3 MECHANISMS OF TRAUMATIC BRAIN INJURY 
TBI is characterized by a wide spectrum of mechanisms of injury and pathological features. 
The three major forms of head trauma include penetrating, blunt and inertial injury. These 
different forms of injury can result in either focal or diffuse brain damage. 
Penetrating brain injury involves the breaching of the skull by an object and the consequent 
piercing of the brain. Penetrating head injuries initiate a combination of contact and inertial 
forces that result in a sequence of events that vary with the size of the impacting object and 
the magnitude of the force delivered to the contact point. This combination of forces often 
results in focal brain damage characterised by laceration of the scalp, extradural 
haematoma, surface contusions and lacerations, and intracerebral haemorrhage (Graham, 
1996). An example of a penetrating head injury is a gunshot wound to the head. Penetrating, 
head injuries, despite their severity, account for the minority of brain injury cases reported 
in Australia (McDermott et al., 2004). 
Blunt and inertial brain injuries account for the majority of head trauma cases and result 
from the rapid movement of the brain within the cranium (Fig 1.1). In blunt head injury 
cases this usually occurs following a contact injury, which results from an object striking 
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Figure 1.1 TBI occurs following the rapid acceleration/deacceleration of the head. In 
this regard, the rapid movement of the head causes the the brain to move and strike 
the skull. Axons are particularly vulnerable to mechanical forces and thjs can cause 
them to twist (A), tear (B) and/or break (C). In the majority of DAI cases, there is no 
immediate severing of the axon. 
Adapted from Anatomy and functions of the brain, Mechanisms of closed head injury. 
www.doctorlawyer.net. 
the head (or vice-versa) leading to focal injuries such as scalp laceration, extradural 
haematoma and skull fractures. Non-contact injuries (inertia brain injury) such as the rapid 
acceleration/deceleration of the head results in head injuries caused solely by inertia of the 
brain relative to the movement of the head (translational, rotational, angulation). Under 
these latter conditions, skull fractures do not occur. Inertial injury forces (can also be 
referred to as impulsive loading) cause mechanical strains that operate in a "centripetal 
sequence" (Ommaya and Gennarelli, 1974; Gaetz, 2004). With mild forces, the sequence 
begins at the surface of the brain and progressively affects the deeper structures as forces 
become more severe. The physicist Holbourn (1943) examined the effects of 
acceleration/deceleration force but in a gelatine model of the brain, and described how 
shear strain occurred in the CNS. He suggested that rotational acceleration forces are the 
primary cause of injury producing predictable damage to the brain. Subsequent studies 
illustrated that the direction of rotation also determined the severity of injury and recovery 
(Gennarelli et al., 1982). Sagittal (front to back) rotational injuries were associated with 
good recovery, conversely, lateral (side to side) rotational injuries resulted in persistent 
coma or severe disability. 
The two most important and common types of damage caused by inertial forces are acute 
subdural haematoma resulting from tearing of subdural bridging veins and widespread 
damage to white matter in the form of diffuse axonal injury (DAI) (Jafari et al., 1997, 1998; 
Maxwell et al., 1997; Adams et al., 2000; Finnie and Blumbergs, 2002; Longhi et al., 
2005). Diffuse brain injuries, particularly DAI, are of particular importance due to their 
high frequency in most head injury cases and their difficulty to be detected by current 
scanning techniques (Povlishock et al., 1992, 1996; Pettus et al., 1994; Jafari et al., 1998; 
Adams et al., 2000; Thompson e! al., 2006). 
1.3.1 Diffuse axonal injury 
Diffuse axonal injury is a common and important pathological feature of TBI. Previously 
undetectable in vivo, DAI affects major axonal bundles within the brain, particularly the 
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cerebral hemispheres, contributing to a clinical pattern involving slowing, inconsistency, 
distractibility, and impaired top-down control classically observed in patients with TBI 
(Levine et al., 2007). Even injuries classified as mild (the majority of reported cases) can 
result in persistent neuro-behavioural impairment (Kraus et al., 2007). It has been suggested 
that DAI is primarily initiated by ionic homeostatic disruption and altered permeability of 
the axolemma rather than instantaneous nerve cell death. In this regard, initial axolemma 
disruption has been linked to the onset of subtle axonal abnormalities, which become 
progressively severe over time, ultimately culminating in a delayed neuronal degeneration 
referred to as secondary axotomy (Povlishock and Christman, 1995; Gennarelli, 1996; 
Graham, 1996; Maxwell et al., 1997). Secondary axotomy is characterized by focal 
swelling followed by disconnection of the two axonal segments, the formation of 
'retraction balls' and Wallerian degeneration of the distal component. Studies of human 
(Blumbergs et al., 1989; Grady et al., 1993) and various experimental models (Maxwell et 
al., 1991; Yaghmai and Povlishock, 1992; Pettus and Povlishock, 1996; Dunn-Meynell and 
Levin, 1997; Jafari et al., 1997; Povlishock et al., 1997) of delayed axonal pathology 
following trauma have indicated that abnormalities in the organization of cytoskeletal 
elements may play an important role in the neuronal response to injury. As with other 
models of axonal damage, DAI may also be associated with the development of neuronal 
mitochondrial changes, abnormal lamellar bodies, the disruption and/or loss of 
microtubules and focal demyelination (Maxwell et al., 1997). 
1.4 THE NEURONAL CYTOSKELETON 
The cytoskeleton is one of the major components of the neuron. This internal support 
system not only defines the architecture of the cell (Fig 1.2) but also plays a pivotal role in 
cell division, cell guidance (particularly in development), cellular transport, anchoring and 
compartmentalization (Dent and Gertler, 2003). Structural and functional alterations to the 
neuronal cytoskeleton play an important role in the mechanism of pathological .change 






Figure 1.2 Diagrammatic representation of the neuronal cytoskeleton 
The neuronal cytoskeleton is composed of three fibrillar systems , 
microfilaments, neuronal intermediate filaments (neurofilaments) and 
microtubules. Neurofilaments, unlike microfilaments and microtubules, are 
composed of subunits with a filamentous structure. The diameter of 
neurofilaments is intermediate between microfilaments and microtubules. 
Adapted from Bear M, Connors B and Paradiso M; Neuroscience: Exploring the brain, 
Maryland, 200 J, Lippincott Williams & Wilkins. 
The neuronal cytoskeleton comprises three main fibrillar systems, which are the 
microtubules (MTs), microfilaments and intermediate filaments (IFs). Each has a 
characteristic composition, structure and organization that may be further specialized in a 
particular cell type or subcellular domain. The defining structural elements have long been 
identifiable in electron micrographs (Dent and Gertler, 2003), and a considerable amount is 
known about the detailed organization of these components. 
1.4.1 Microtubules 
Biochemically, MTs are long unbranched polymers of 50-kDa tubulin subunits. 
Heterodimers of a and B-tubulin are aligned end to end to form protofilaments, which are 
arranged laterally into a tubular structure, the walls of the MT polymer, with an external 
diameter of approximately 25nm and inner light core, 15nm in diameter (Hirokawa, 1994). 
A variety of post-translational modification sites are available on neuronal MTs and twenty 
isoforms of tubulin can be identified using isoelectric focusing. For example, the principal 
modifications include acetylation of a-tubulin by tubulin acetylase, phosphorylation of B-
tubulin by casein kinase II and the tyrosination/detyronisation of a-tubulin by tubulin ligase 
(Mullins et al., 1994; Utreras et al., 2008;). Detyrosinated and acetylated a-tubulins are the 
most studied modifications and appear to be associated with more stable MT populations 
(Lanfanchere and Job, 2000). The majority of a-tubulins are expressed with a carboxy-
terminal tyrosine residue, which can be cleaved by tubulin carboxypeptidase and then 
replaced by tubulin tyrosine ligase, in a rapid cycle involving all available tubulin. Since 
the carboxypeptidase acts only on assembled tubulin and the ligase acts on unassembled 
tubulin, this tyrosination/detyrosination cycle is linked to MT dynamics (Myers et al., 
2006). 
MT composition, modification and organization varies according to their localisation to 
specific cellular compartments, which suggests that MTs exist in specialized forms to 
perform designated tasks in the unique environments of the neuron. This is particularly 
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evident for axonal MTs, which contain stable segments that are unusually resistant to 
treatments that depolymerize MTs in other cells. These stable domains may serve to 
organize MTs in axons, particularly during regeneration (Brady, 1993). 
MTs play an important role in axonal transport in nerve cells. They are responsible for the 
bi-directional movement of membrane bound organelles along axons and dendrites (Baas et 
al., 2006). This is facilitated by the molecular motors kinesin (Myers et al., 2006), for 
anterograde transport and dynein (Hirokawa et al., 1998), which is responsible for 
retrograde transport. The other proposed functions of MTs include maintenance of neuronal 
morphology, cell division and motility in development, and importantly neuroplasticity 
following injury (Bouquet et al., 2004). 
MTs are highly dynamic and play an important role in the elongation of axons and the 
guidance of growth cones (Dent et al., 1999). In this regard, MTs interact with actin 
filaments within the growth cone (Dent et al., 1999). Initially it was assumed that changes 
in the organization of MTs at the growth cone occur secondarily, as a consequence of 
formation and disassembly of actin filaments. However, further studies of cytoskeletal 
dynamics observed in living growth cones revealed that MTs do not remain passively 
bundled in the growth cone centre (Dent and Kalil 2001; Schaefer et al. 2002). Other 
studies have demonstrated that attractive growth cone turning can be initiated by localized 
MT stabilization in conjunction with actin dynamics (Buck and Zheng, 2002). Recently, it 
has been shown that MTs themselves can be a direct target of guidance cues in controlling 
of growth cones and regulating axon elongation (Lee et al., 2004; Zhou et al., 2004). MTs 
not only play a vital role during development but also modulate the post-injury sprouting 
response (Chuckowree and Vickers, 2003). However, MTs are not restricted to growth 
cones and can dynamically reorganize to form axon collateral branches (Dent and kalil, 
2001; Schaefer et al., 2002; Wang and Brown, 2002). In this regard, calcium transients are 
proposed to play an important function in modulating MT dynamics (Dent et al., 2004; 
Hutchins and Kalil, 2008). 
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1.4.1.1 Microtubule Associated Proteins 
Microtubule-associated proteins (MAPs) are a heterogeneous group of proteins, which co-
purify with MTs (Avila et al., 2008). MAPs display a complex expression pattern during 
development and have a high degree of specificity within different neuronal cell types 
(Matus, 1998). MAPs associate with MTs rather than free tubulin and remain in constant 
stoichiometry with the tubulin in MTs through cycles of assembly and disassembly. MAPs 
are primarily cytoskeleton structural components, involved in MT-dependant organization 
of the cytoplasm through interactions with other subcellular components (Avila et al., 
2008). Besides playing a role in the regulation of MT assembly, MAPs also participate in 
axonal transport along MTs (Dehmelt et al., 2006). 
MAPs are separated into two broad groups based on their molecular weights. Typically, the 
high weight MAPs include lA, lB, 2A and 2B (>270 kDa). The tau proteins are a major 
component of the low molecular weight MAPs (30-60 KDa) (Maccioni and Cambiazo, 
1995; Avila, 2006; Lace et al., 2007), which also include MAP3 and MAP4, and the 
molecular motors kinesin and dynein, which drive the intracellular transport of membrane-
bound organelles along MT tracts. The two groups of MAPs possess similar carboxy-
terminal amino acid sequences despite the difference in molecular weights. 
1.4.2 Neurofilaments 
Neurofilaments are a type of intermediate filament exclusively expressed within neuronal 
cells, most prominently in large axons. Intermediate filaments are intermediate is size 
between actin filaments and MTs, only in their average diameters, ranging from 10-15 nm 
compared to 8 nm for filamentous (F)-actin and 23 nm for MTs. NFs interact with each 
other both in vitro and in vivo without the aid of other proteins, to form bundles and 
networks mediated by long flexible polypeptide chains, called sidearms that emanate from 
the surface of the core polymer (Fig 1.3). Six distinct classes of proteins are now regarded 
as potential mammalian NF subunits, and these are classified on the basis of similarities in 
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Figure 1.2 Diagrammatic representation of type IV neuronal intermediate filament 
proteins. A, Type IV neuronal intermediate filament proteins include the 
neuro:filament triplet proteins, NFL, NFM and NFH, commonly referred to as 
neuro:filaments, as well as a-intemexin. These proteins comprise the main 
intermediate :filament component of the cytoskeleton of most mature CNS neurons. 
Neuronal intermediate filaments have a distinct filamentous structure. B, 
Neurofilament triplet proteins are polymers of NFL, NFM and NFH subunits. 
NFM and NFH possess carboxy terminal tail domains (or ' side-arms') that 
protrude from the core filament, vary in length between sub-units and undergo 
phosphorlylation to increase inter filament spacing. 
Adapted from Lariviere R and Julien 1-P: Functions of intermediate filaments in neuronal 
development and disease: J.Neurobiol, 2004, 58 131-148. 
sequence and gene structure. These classes are: vimentin (class III), peripherin (class III), 
a-intemexin (class IV), nestin and a group of three related NF subunits, known as the NF 
triplet proteins. The NF triplet proteins are designated as NFL, NFM and NFH for, 
respectively, low- (68kDa), medium-(160kDa) and high-molecular-weight (205kDa) 
subunits (Perrot et al., 2008). The NF triplet subunits share sequence and structural 
similarity in a coiled core domain, but differ in the length and sequence of their N-termini 
and more dramatically of their C-termini, which in the case of the medium (NFM) and 
heavy chains (NFH) of NFs form the flexible extensions that link NFs to each other and to 
other elements in the cytoplasm. 
NFs role, together with micro tubules and microfilaments, is to enhance structural integrity, 
cell shape, and cell and organelle motility. In addition, a major function of NFs, particularly 
in phosphorylated forms, is related to control of axonal calibre (Nixon and Shea, 1992). A 
central role for NFs in maintaining and regulating axon calibre has been highlighted by the 
failure of radial axon growth following targeted deletion of the NFL protein (Zhu et al., 
1997). This is not only of structural significance but also important because the speeds of 
conductivity of an impulse down the axon is proportional to its calibre (Hirokawa and 
Takeda, 1998; Julien, 1999). Studies have analysed the importance of the number and 
stoichiometric proportion of each NF subunit in the axonal calibre determination (Perrot et 
al., 2008). The over-expression of NFL in transgenic mice, which leads to a two to 
threefold increase in the number of NFs, did not significantly alter the diameter of the 
axons (Monteiro et al., 1990; Xu et al., 1996). This suggests that NF number alone is 
unlikely to be the principal determinant of axon calibre. However, the co-overexpression of 
either NFL-NFM or NFL-NFH increases the axonal calibre (Xu et al., 1996; Meier et al., 
1999). Altogether these results indicate that both the number of NFs and a precise 
stoichiometry of their subunits are essential for radial growth of the axon. 
As part of complex and dynamic network, NFs also interact with a number of substrates, 
and these are principally mediated through NP-associated proteins that can modulate 
structure (linker proteins) and function (enzymes) (Perrot et al., 2008). Linker proteins are 
responsible for the interaction between the different filaments or organelles, whereas 
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enzymes (which include mainly kinases and phosphatases) modulate NF architecture, 
assembly and spacing (Perrot et al., 2008). There is a dynamic relationship between NFs 
and MTs, particularly within the axoskeleton, which is modulated by phosphorylation 
(Leterrier et al., 1984; Minami et al., 1984; Miyasaka et al., 1993). Other studies have 
illustrated a direct interaction between motor protein dynein and kinesin and NFs (Y abe et 
al., 1999, 2000; Shah et al., 2000; Wagner et al., 2004; Theiss et al., 2005; Motil et al., 
2006). Additionally, it has been reported that NFs were able to bind DNA, RNA and 
histone H 1 nuclear protein, suggesting a possible role of NF in the regulation of 
transcription processes (Traub et al., 1987; Wang et al., 2001; Perrot et al., 2008). In regard 
to organelles, NFs have been shown to form cross-bridges with mitochondria (Hirokawa, 
1982; Leterrier et al., 1994) and dynamic complexes with smooth endoplasmic reticulum 
(Metuzals et al., 1995). It is important to note that the majority of these interactions are 
regulated by NF phosphorylation, which will be further discussed later. 
NFs may also have a neuroprotective effect and promote cell survival. This was 
demonstrated by crossing transgenic mice over-expressing human NFH and mice 
expressing a mutant superoxide dismutase (SOD1G32R) linked to human amyotrophic 
lateral sclerosis (ALS), which resulted in an increase in the lifespan of the progeny by 65% 
(Couillard-Despres et al., 1998). Additionally, the double transgenic mutant mice over-
expressing peripherin and human NFH transgenes were almost completely protected from 
peripherin-mediated degeneration of neurons in vivo (Beaulieu and Julien, 2003). The over 
expression of human NFH resulted in the movement of the intracellular peripherin 
localization from the axonal compartment to the perkaryal compartment of spinal cord 
motor neurons. These results suggest that NFH plays a role in the sequestering of 
peripherin, preventing the detrimental development of intermediate filament inclusions, 
which may result in disruption to axonal transport. There is also significant evidence to also 
suggest that NF proteins play complex roles in the control of ionic balance. For example, 
modifications to NFH and NFM is shown to be particularly capable of assimilating stress-
related adducts, such as the release of toxic aldehydes generated from oxidative damage, to 
balance cellular conditions, until they are degraded at the synapse or modifications are 
reversed in the cytoplasm (Wataya et al., 2002; Chou et al., 1998; Leski et al., 2001). 
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Both NFM and NFH tails consist of four regions of random coils. The second acidic amino-
acid-rich region produces an extended structure, which may imply a spacing function 
possibly ensuring that the carboxy-terminus portion of the subunits are positioned remote 
from the rod domain (Fig. l.3B). These projecting tail regions may also correspond to the 
unique side arm structures observed in ultrastructural studies. A series of multiple lysine-
serine-proline (KSP) repeats are located beyond this region, which may be reversibly 
phosphorylated. The phosphorylation of NFs induces conformational changes and is 
involved in modifying NF size, morphology and dynamics, especially following damage 
and in diseased states (Julien, 1999; Brownlees et al., 2002; Shea et al., 2003). 
1.4.2.1 NF Phosphorylation 
NF phosphorylation plays a critical role in the regulation of filament translocation, 
formation and function and may also be involved in the pathogenesis of certain 
neurodegenerative diseases. The phosphorylation of NFs is topographically regulated, with 
a proximo-distal gradient consisting of an intense phosphorylation in axons and little or no 
phosphorylation in cell bodies and dendrites (Nixon and shea, 1992; Nixon et al., 1994). 
The phosphorylation sites on the three NF subunits are located on the amino-terminal and 
carboxy-terrninal domains, and these are targets of second messenger- dependant and 
independent kinases respectively (Sihag and Nixon, 1989, 1990; Perrot et al., 2008). 
NF phosphorylation has multiple important roles. The major function is the regulation of 
axonal radial growth. There is extensive phosphorylation of the KSP repeats in the tail 
domain of NFM and NFH in axons. This results in the formation of NF sidearms, increased 
intemeuronal spacing, radial growth of axons and, consequently, increased conduction of 
velocity (de Waegh et al., 1992; Nakagawa et al., 1995; Yin et al., 1998). As mentioned 
above NF phosphorylation also regulates MT-NF and NF-dynein/kinesin interactions 
(Motil et al., 2006; Perrot et al., 2008). The loss of NFM and NFH phosphorylation in 
demyelinated axons, suggests a link between myelination and NF phosphorylation (de 
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Waegh et al., 1992). The role of NF phosphorylation in axonal transport supported by 
studies, some analysing the movement of GFP-tagged phosphorylation mutants of NFH in 
neurons, illustrating NFH side-arm phosphorylation as a regulator of NF transport 
(Ackerley et al., 2000; Shea et al., 2003; Yabe et al., 2003). 
Alterations to NFs have been associated with many neurodegenerative diseases and also 
may have a significant role in the secondary degeneration of injured axons (Chuckowree et 
al., 2004; Povlishock and Katz, 2005; Kesavapany et al., 2007). Indeed, the pathological 
accumulations of NFs are an important pathological feature of DAI and (Dickson et al., 
2000; Smith et al., 2003; Chen et al., 2004) neurodegenerative disorders such as 
Alzheimer's disease (Vickers et al., 1996; Dickson et al., 1999), Parkinson's disease 
(Spillantini et al., 1998 Trimmer et al., 2004), and amyotrophic lateral sclerosis (Murayama 
et al., 1992). 
1.5 NEURONAL RESPONSE TO INJURY 
The neuronal response to injury involves a number of cellular and molecular mechanisms 
and is directly dependant on the severity of the injury. Immediate severing of axons at the 
time of injury, termed primary axotomy, results in rapid neuronal degeneration (Smith and 
Meaney, 2000). This only occurs at the most severe levels of injury, and in most 
circumstances, mechanical trauma induces a delayed cell death (Maxwell et al., 1997). This 
delayed cell death has been demonstrated in a number of human and animal studies, yet it is 
evident that this process involving a number of cellular and molecular pathways is more 
complex that previously believed (Smith and Meaney, 2003; Povlishock and Katz, 2005). It 
has been proposed that the neuronal response to injury is characterized by altered 
axolemma permeability, cytoskeletal disruption, and the induction of a number of cell death 
pathways ultimately resulting in cell death (Buki et al., 1999; Smith and Meaney, 2003). 
1.5.1 Altered axolemma permeability 
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Many in vitro and in viva DAI studies, utilising either extracellular tracer infusion 
techniques or tracers typically excluded from the neuronal cytoplasm, have illustrated 
microscopic mechanoporation of the axolemma (Geddes et al., 2003; Prado et al., 2005). 
This mechanoporation was believed to play a significant role in DAI and result in the 
detrimental influx of ions, particularly calcium, through the compromised cell membrane 
(Singleton and Povlishock, 2004). Altered axolemma permeability to calcium has long been 
associated with TBI (Povlishock and Pettus, 1996; Maxwell et al., 1997; Okonkwo et al., 
1999). The implications of increased intra-axonal calcium will be discussed in detail in the 
following section, but it is important to note that current thought holds that injury induced 
mechanoporation of the axolemma results in abnormal influx of calcium which in tum 
triggers various proteases and phosphatases resulting in cytoskeletal degradation and/or 
neuronal death (Buki et al., 2000; Buki and Povlishock, 2005). 
Evidence for the possible involvement of calcium in TBI is based on the finding that 
calcium in the cerebrospinal fluid decreases from 1 to O.OlmM following head trauma 
(Young, 1992; Nilsson et al., 1993). Additionally, total brain tissue calcium uptake is 
increased following in viva injury (Hovda et al., 1992; Fineman et al., 1993). These results 
support the notion that total intracellular calcium is elevated in the cells of the CNS after 
TBI. However, there are several intracellular calcium stores within the neuron including 
calcium bound to the plasma membrane, cytoskeletal components, and calcium-binding 
proteins; calcium stores in the endoplasmic recticulum, mitochondria, and nucleus; and 
intracellular free calcium (Kostyuk and Verkhratsky, 1994; Weber et al., 2001). It is 
unclear what the distribution of calcium in these stores are following TBI (Weber et al., 
2001). 
The role of altered axolemma permeabilty in the eventual death of the neuron following 
DAI is controversial (Farkas et al., 2006). Following the early studies of injury induced 
disruption to axolemma permeability (Povlishock and Christman, 1995; Gennarelli, 1996; 
Graham, 1996; Maxwell et al., 1997), recent studies have revealed that neurons respond 
heterogeneously to injury induced axolemma disruptions (Farkas et al., 2006). Specifically, 
some neurons with membrane disruption had ultrastructural evidence of neuronal necrosis, 
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as determined using Fluoro Jade. In contrast, other neurons sustaining membrane disruption 
did not show comparable signs of overt cell damage (Farkas et al., 2006; Farkas and 
Povlishock, 2007). Additionally, different populations of injured neurons, at the same time 
and in the same brain foci, did not illustrate axolemma disruption yet they demonstrated 
either the induction of heat-shock protein expression and/or calpain mediated spectrin 
proteolysis (Farkas and Povlishock, 2007). These divergent responses to axolemma damage 
suggest that mechanoporation may not ultimately lead to neuronal death or that there is a 
potential for membrane resealing and recovery following injury. 
Despite divergent results on the significance of axolemma alterations following injury, 
other studies have illustrated increased intracellular calcium levels within injured axons and 
suggest an extracellular source for the calcium influx (Iwata et al., 2004). Disruption to 
axolemma permeability is not seen following axonal stretch injury (Smith et al., 1999) and 
further studies by Wolf and colleagues (2001) also indicated no evidence of calcium entry 
through mechanically produced pores. However, calcium-mediated proteolytic cleavage of 
tetrodotoxin-sensitive sodium channels resulting in an influx of calcium has been illustrated 
following stretch injury but the initial source of increased cytosolic calcium remains to be 
elucidated (Iwata et al., 2004). Traumatic stretch injury to cultured cortical neurons resulted 
in alterations in intracellular calcium stores and capacitative calcium influx (Weber et al., 
1999, 2001, 2002). In this regard, intracellular calcium stores located on the endoplasmic 
reticulum are reported to play an important role in the post-injury intracellular calcium 
homeostasis (Weber et al., 2001, 2002). Although intracellular calcium levels return to 
basal levels following release from stores (induced either by stretch injury or thapsigargin 
treatment), these calcium disruptions alter calcium signalling population dynamics, which 
could affect normal neurotransmission in the brain and contribute to some of the pathology 
of TBI (Weber et al., 2001, 2002). 
1.5.1.1 Calcium dysregulation 
The influx of calcium ions through voltage-dependant and ligand-gated channels in the 
plasma membrane is a critical signal for the release of neurotransmitters from presynaptic 
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terminals and for responses of the postsynaptic neuron (Majewska et al., 2000; Burnashev 
and Rozvov, 2005; Hartmann and Konnerth, 2005). The intracellular concentration of 
calcium increases only transiently during normal physiological functioning. The regulation 
of these calcium fluxes is disrupted following injury, in diseased states and more 
insidiously in normal aging (Weber et al., 2001). In these circumstances the ability of 
neurons to control calcium fluxes, recovering from an increased calcium load, results in 
oxidative stress. Additionally, calcium can affect the integrity of the neuronal cytoskeleton. 
Calcium alone is capable of precipitous disassembly of cold-labile microtubules (Pettus and 
Povlishock, 1996). Although not all microtubules are disrupted directly by calcium, 
microtubules are depolymerised when calcium interacts with calmodulin under normal 
physiological conditions (Job et al., 1981). Calcium both prevents microtubule assembly 
and induces a rapid disassembly of pre-existing polymers (Maxwell et al., 1997). 
Increased intracellular calcium levels may also result in the activation of cysteine proteases 
(calpains) and phosphatases (calcineurin and calmodium). Calpains degrade a number of 
substrates including cytoskeletal proteins, membrane receptors and metabolic enzymes (Bi 
et al., 1996; Caba et al., 2002; Guttmann et al., 2002) and may also activate of a variety of 
caspases (Leist et al., 1997; Volbracht et al., 2001), which is a pivotal component in the 
initiation of apoptosis. Calpain activation and decreased calpain inhibition by calpatatin 
have been linked to NF degradation, although this may only be a posttranslational 
modification (Povlishock, 2000). Activated calpains seem to play a role in the early 
degradation of neuronal spectrin (Okonkwo et al., 1998; Povlishock, 2000). In this regard, 
calpain mediated spectrin proteolysis has also been shown to directly contribute to the 
proteolytic sidearm modification of NFs resulting in NF compaction (Buki and Povlishock, 
2005). Relatedly, axotomy of Mauthner axons in the lamprey induces a large influx of 
extracellular calcium that correlates well with the temporal pattern of NF sidearm 
proteolysis (Strautman et al., 1990; Hall and Lee, 1995). 
Alternatively, calcium-induced activation of calcineurin can occur, which may modify the 
phosphorylation state of NF sidearms, thereby altering the repelling forces of the sidearms, 
resulting in NF compaction (Okonkwo et al., 1998; Buki and Povlishock, 2005). 
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Calcineurin is a heterodimer, which consists of a catalytic subunit (calcineurin-A) with a 
molecular mass of about 57-59 kDa and a regulatory calcium-binding subunit (calcineurin-
B) with a molecular mass of 19 kDa (Klee et al., 1988). Ubiquitously distributed in 
eukaryotes and widely distributed in the brain, calcineurin, is highly expressed in the 
hippocampus, except for intemeurons (Siket al., 1998), and the caudate putamen (Klee et 
al., 1988; Steiner et al., 1992; Halpain et al., 1998). Calcineurin-A is found in cell bodies, 
postsynaptic densities, dendrites, axons, and spines commonly located in the cytosol or 
associated with the plasµrn membrane within the cell (Klee et al., 1988; Wu et al., 2007). 
Calcineurin has also been shown to be associated with the cytoskeleton. This finding is of 
interest given that several substrates of calcineurin are co-localised to the cytoskeleton 
including tau (Garver et al., 1999; Goto et al., 1985; Kayyali et al., 1997), microtubule-
associated protein 2, tubulin (Goto et al., 1985), dystrophin (Michalak et al. 1996), and 
dynamin (Liu et al., 1994). As a serine/threonine protein phosphatase, calcineurin acts as an 
effector of calcium signalling by regulating the phosphorylation state of these cytoskeletal 
proteins. As a result calcineurin activity is linked to calcium-induced cytoskeletal damage 
following injury. The general implications of cytoskeletal alterations, including NP 
compaction will be discussed in detail in the following sections, but one of the more 
significant calcium-mediated cytoskeletal alterations is damage to the mitochondria. 
Spectrin can cross-link mitochondria with other organelles (Peters et al., 1991) and 
following injury calcium mediated spectrin proteolysis appears on the surface of swollen 
mitochondria (Buki et al., 1999). This may suggest that the proteolysis of spectrin is related 
to mitochondrial damage. 
1.5.1.2 Mitochondrial damage and release of cytochrome-C 
Axonal injury is associated with alterations to the mitochondria including swelling and the 
rupture of the mitochondrial cristae (Buki et al., 1999). These mitochondrial alterations are 
reminiscent of those induced by calcium mediated opening of the mitochondrial 
permeability transition (MPT) pore and is proposed to be mediated by the excessive 
sequestration of calcium following injury (Buki and Povlishock, 2005). Mitochondrial 
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injury provides a further energetic and homeostatic challenge for the injured neuron. The 
release of calcium from mitochondrial stores may also further exacerbate the neuronal 
response to injury. Mitochondrial injury can also result in the activation of the caspase 
death cascade due to MPT-mediated release of pro-apoptotic substances such as 
cytochrome-C and apoptosis inducing factor (AIF) (Jiang and Stys, 2000). 
Cytochrome-C release from mitochondrial stores following injury is a critical event in the 
mechanism of neuronal death. When released into the cytosol cytochrome-C forms the 
apoptosome with Apaf-1 and pro-caspase-9 resulting in caspase-3 activation. Despite its 
importance in neuronal cell death very little about the mechanism(s) of cytochrome-C 
release is known. Most studies have focused on the release of cytochrome-C via 
mitochondrial permeabilization and its regulation by members of the Bcl-2 family (Buki et 
al., 1999; Buki and Povlishock, 2006). Recent insights have emerged on the underlying 
mechanism for cytochrome-C mobilization from the mitochondrial inner membrane, which 
is a prerequisite for its release. Under physiological conditions cytochrome-C can function 
as a mitochondrial electron carrier. However, following a pro-apoptotic insult cytochrome-
C may play a role as a specific perioxidase (Kagan et al., 2006). The majority of 
cytochrome-C is loosely attached to the inner mitochondrial membrane and can be easily 
detached using an ionic salt. This fraction of cytochrome-C participates in electron 
transport and superoxide scavenging (Okouchi et al., 2007). The remaining amount of 
cytochrome-C is tightly bound to a phospholipid unique to the mitochondrial inner 
membrane known as cardiolipin (Okouchi et al., 2007). The cytochrome-C bound 
cardiolipin exhibits peroxidase activity that eliminates mitochondrial derived H20 2 and is 
important in apoptosis (Chen et al., 2002). The disruption of mitochondrial electron 
transport following a calcium associated traumatic insult induces the generation of 0 2- and 
H20 2 , which promotes the peroxidase activity of the cytochrome-C bound to the 
cardiolipin. This initiation of peroxidase activity results in the dissociation of cytochrome-
C. This release of cytochrome-C is referred to as "two step" (Gogvadze et al., 2006) with 
the first step involving cytochrome-C detachment from cardiolipin at the inner membrane 
upon oxidation of the phospholipids. The second step involves cytochrome-C release into 
the cytosol through Bax/Bak outer membrane permeabilization (Ott et al., 2002). 
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The use of potent mitochondrial pore blockers, such as cyclosporin-A, to prevent the 
release of cytochrome-C provided not only profound mitochondrial protection but also a 
significant blunting of the above described calpain-mediated spectrin proteolysis and 
related cytoskeletal changes (Btiki et al., 1999b; Okonkwo and Povlishock, 1999; Okonkwo 
et al., 1999). However, not all cytoskeletal alterations, for example NF compaction 
(Okonkwo and Povlishock, 1999), were attenuated following injury highlighting the 
complexity of DAI and the possible involvement of other calcium-mediated pathways, 
which need to be further examined. 
1.5.2 Cytoskeletal response to injury 
As an integral support component of the neuron, NFs are particularly at risk to damage. 
NFs stabilize the neuronal structure and provide tensile strength. An increased population 
of NFs within a neuron will provide neurons the mechanical strength necessary to resist the 
compressive forces of the local environment (Cleveland et al., 1991). The NF alterations 
following injury have been extensively studied in both in vitro (Dickson et al., 2000; 
Chuckowree and Vickers, 2003) and in vivo (King et al., 2000; 2001) models involving 
axon transection (Meller et al., 1993). These studies have demonstrated accumulations of 
NFs into ring- and bulb-like structures in severed axonal stumps. Both structures lacked 
microtubules and appeared to contain a dense core of organelles, surrounded by a whorl 
(forming a ring-like structure) or dense ball (forming a bulb-like structure) of NFs. 
Morphologically similar structures were also observed in a subtype of AB plaque-associated 
dystrophic neurites in Alzheimer's disease (King et al., 2000). The accumulations of NF 
proteins at the transected axonal tips often persist for long periods of time, with the NFs 
remaining bundled (Hall and Lee, 1995; Nixon, 1998). 
There is a spectrum of pathologic changes that are observed in non-disruptively (unsevered) 
injured axons, which is based on the severity of the injury as well as the size of the axons. 
However, it is well understood that in mild injuries, in which there is no disruption to the 
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axolemma, there is a misalignment of the NFs and microfilaments without any loss of 
microtubules (Pettus et al., 1994; Pettus and Povlishock, 1996; Jafari et al., 1997; Maxwell 
et al., 1997). This may support the finding that at milder levels of compression injury, 
axons can completely recover (Maxwell et al., 1997). At moderate to severe injuries there is 
a compaction of the NFs (Pettus et al., 1994; Pettus and Povlishock, 1996; Jafari et al., 
1997), reducing the spacing between adjacent NFs, and loss of microtubules. NF 
compaction, leading to an increased density of NFs within the axoplasm, may occur within 
5 minutes of injury persisting for months, and it is established that there is little change in 
the compaction between this time period (Pettus et al., 1994; Pettus and Povlishock, 1996). 
There is quantitative and morphological evidence of microtubule loss in both moderate and 
severe levels of axonal injury (Hoffman et al., 1984, 1985; Jafari et al., 1997, 1998; 
Maxwell and Graham, 1997; Adlard et al., 2000). The post-injury reduction in microtubules 
has been demonstrated in large pontomedullary nerve fibres in cats (Povlishock et al., 
1995), smaller optic nerve fibres of the guinea pig (Maxwell et al., 1994; Maxwell, 1995, 
1996) and in myelinated axons of the human cortex (Castejon and Acurero, 2004). The loss 
of microtubules is most notable at the nodes of Ranvier (Maxwell. 1996) where, in non-
injured controls there is significantly higher levels compared to NFs (Maxwell and Graham, 
1997). Fast axonal transport continues in areas where microtubules remain intact, distant to 
the focal area of their loss. Microtubules and their associated proteins are fundamental to 
the process of axonal transport, continuously moving membrane bound vesicles to distal 
axonal regions. It is still unclear whether there is morphological and functional recovery 
from microtubule misalignment, but recent studies demonstrated pharmacological 
microtubule destabilization of sensory neurons in cell culture induces retraction bulb 
formation (Erturk et al., 2007). 
1.5.2.1.1 Axonal transport disruption 
Impairment of axonal transport and the subsequent development of axonal swellings appear 
to be associated with a sequence of axonal changes underlying DAI. Two mechanisms of 
axonal damage have been suggested to lead to the impairment of axonal transport. The first 
19 
mechanism involves axon swelling due to a change in ionic influx. The pathological influx 
of sodium through sodium channels has been well characterized in both models of white 
matter anoxia and dynamic stretch of axons (Stys et al., 1992; Waxman et al., 1992; 
Waxman et al., 1994; Wolf et al., 1999; Li et al., 1999; Agrawal et al., 1996). This 
disruption to ionic homeostasis may result in osmotic swelling of axons due to sodium 
influx; the resultant increase in intracellular calcium may also induce the deleterious 
activation of proteases leading to additional cytoskeletal damage as previously discussed 
(Saatman et al., 1996; Pike et al., 1996; Buki et al., 1999; McCracken et al., 1999). 
Although the disruption in ionic homeostasis may play an important role in the 
development of axonal swellings and contribute to the eventual demise of the injured axon, 
it is not considered to be the principal pathological feature of traumatically injured axons. 
Rather, the accumulation of axonal transport proteins within axon swellings is reported to 
be a major contributor to cell death following injury. Studies utilizing a variety of markers 
have illustrated the accumulation of fast transport ~-amyloid precursor protein (~APP) and 
the slow transport NF proteins (Yaghmai et al., 1992; Gentleman et al., 1993;Grady et al., 
1993; Blumbergs et al., 1995; Pierce et al., 1996). 
The second proposed mechanism of axonal damage relates to perturbation in the 
organization of NF subunits and microtubules as a direct result of the mechanical forces 
underlying TBI. Single-labelling immunocytochemical studies using antibodies that may 
indicate NF compaction, RM014, and antibodies to APP, a marker of impaired axonal 
transport, have shown that axonal injury involves both NF compaction and disruption of 
axonal transport (Buki et al., 1999; Okonkwo et al., 1999). Initially these events were 
proposed to occur within the same injured axon. Further studies, however, demonstrated 
that not all traumatically injured axons progressed to form axonal swellings and in some 
axons NF compaction occurred independently of impaired axonal transport and swelling 
(Stone et al., 2001). In this regard, Marmarou and colleagues (2005) provided quantitative 
analysis of the relationship between NF compaction and impaired axonal transport. This 
study illustrated that in the majority of damaged axons, NF compaction was not associated 
with impaired axon transport and further demonstrated the importance of multiple markers 
when evaluating the extent of axonal injury (Marmarou et al., 2005). Recently, the fate of 
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traumatically injured axons with NF compaction was analysed using electron microscopy 
(Gallyas et al., 2006). Quantitative analysis of the injured axons revealed that around 50% 
of the compacted axons recovered in 1 day, and a further 10% did so in 1 week. Electron 
microscopy revealed that the non-recovering compacted axons underwent a sequence of 
degenerative morphological changes including homogenisation, fragmentation and 
resorption of the fragments (Gallyas et al., 2006). Together with alterations to NF structure 
the disassembly of microtubules in axons may also contribute to disruption to axonal 
transport. 
It is currently accepted that these two mechanisms of axonal damage that result in axonal 
transport deficits are not mutually exclusive, and that a number of cellular processes may 
be operating at the same time. The exact physiological changes following TBI are still 
unknown. However, it is clear that disruption to axonal transport resulting in the 
development of axon swellings is a significant contributor to the eventual death of the 
injured neuron. Wallerian degeneration and apoptosis mediated by the ubiquitin proteasome 
system (UPS) are two cell death mechanisms proposed to be involved in the secondary 
degeneration of injured neurons following DAI. 
1.5.3 Wallerian degeneration 
Wallerian degeneration is stereotyped more as sequence of degenerative events following 
injury, than as a cell death mechanism (Zhai et al., 2003; Vargas and Barres, 2007). The 
initial illustration of Wallerian degeneration was observed following transection of a nerve 
(Waller, 1850). In this study, there was progressive degeneration of the distal nerve within 
days following the injury. In the PNS, rapid Wallerian degeneration results in an 
extracellular environment that is conducive to axon regeneration (Griffin et al., 1992; 
Vargas and Barres, 2007). In contrast, Wallerian degeneration within the CNS results in the 
presence of myelin-associated inhibitors that are likely to provide an inhibitory 
environment to axon regeneration (Gillingwater et al., 2006; Buss et al., 2005). Although 
the underlying mechanisms of Wallerian degeneration are still unclear there is evidence of 
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a disrupted intracellular calcium homeostasis, which may result in the activation of the 
calcium-dependent protease calpain (George et al., 1995; Kerschensteiner et al. 2005 Buki 
and Povlishock, 2006; Vargas and Barres, 2007). The pivotal event in the degradation of 
the axon is considered to be the breakdown of the axonal cytoskeleton described as granular 
disintegration of the cytoskeleton, in which fine particulate and amorphous debris replaces 
the axoplasm (Maxwell et al., 2003; Beirowski et al., 2005; Buki and Povlishock, 2006; 
Vargas and Barres, 2007). Smith et al (1999) found that there was still the possibility that 
axons could recover from axonal swellings, proving that axonal bulb formation is the end 
stage event. Initially, it was believed that Wallerian degeneration was a passive process, 
possibly as the result of "starvation" of the cell due to the disruption in axonal transport 
(Zhai et al., 2003). The discovery of a spontaneous mutation in mice called Wallerian 
degeneration slow (Wlds), however, suggests that the degeneration may be an active 
process (Lunn et al., 1989; Tsao et al. 1999, Raff et al., 2002; Vargas and Barres, 2007). In 
these mice, Wallerian degeneration in both the PNS and CNS is greatly delayed. 
Remarkably, the distal portion of a transected Wlds axon can remain viable, and can 
conduct action potentials for up to 3 weeks, as the result of an intrinsic property of the 
mutant axon (Perry et al., 1990; Glass et al., 1993). Later studies have illustrated the 
involvement of the UPS, at least in the early stages of Wallerian degeneration (Zhai et al., 
2003). The pharmacological inhibition of the UPS results in a slowing of Wallerian 
degeneration (Zhai et al., 2003). The mechanisms underlying the UPS involvement in 
Wallerian degeneration remains to be defined, however, it is proposed that the activation of 
the UPS may mediate the degradation of key protein(s) that can then trigger the secondary 
phase of the Wallerian degenerative process (Zhai et al., 2003). 
1.5.4 Ubiquitin proteasome system 
Evidence of ubiquitinated material within axon swellings following DAI and axotomy may 
be indicative of UPS involvement (Schweitzer et al., 1993). In the majority of cells, large 
amounts of newly synthesized proteins are defective "off-pathway" products. This may be 
the result of protein misfolding due to mutations or inefficient assembly (Schubert et al., 
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2000). To avoid these misfolded proteins forming aggregates of high molecular weight 
oligomers, the proteins can be degraded via the UPS system (Berke et al., 2003). Ubiquitin 
(Ub) is a 76 amino acid polypeptide, which mediates a number of cellular processes, 
including degradation, through covalent modification of protein. Addition of a single Ub 
(mono-ubiquitination) regulates protein activity and trafficking within a cell. By contrast, 
the addition of Ub in growing chains (poly-ubiquitination) targets the protein for 
destruction by the multi-subunit 26S proteasome (Ehlers, 2004). 
Ubiquitin is wnjugated to proteins through an isopeptide linkage involving the C-terminal 
carboxylate of Ub and the E-NH2 group of a lysine side chain of the target protein 
(Glickman and Ciechanover, 2002). At least three distinct sets of enzymatic activities are 
involved in the ubiquitination of substrates. These include ubiquitin-activating enzyme 
(El), which forms a thiol ester with the carboxyl group of Gly76, activating the C-terminus 
of ubiquitin. The activated ubiquitin molecule is carried by ubiquitin-conjugating enzyme 
(E2) and transferred to the substrate lysine residue by ubiquitin-ligases (E3). Additional 
ubiquitin molecules can be added to form poly-ubiquitin chains via the terminal carboxyl of 
each ubiquitin linked to the E-amino group of a lysine residue of an adjacent ubiquitin in the 
chain. Ubiquitin can form chains in vivo at all seven lysine residues (K6, K11, K27, K33, 
K29, K48, K63) (Peng et al., 2003). Poly-ubiquitination of chains via the lysine residue 
K48 is the primary signal for protein degradation (Pickart, 2003). K63-linked chains, 
however, are involved in DNA repair, ribosome function, mitochondrial DNA inheritance, 
the stress response and targeting of proteins for endocytosis (Pickart, 2003). For substrate 
recognition and subsequent degradation by the 26S proteasome, a chain of at least four 
ubiquitin moieties need to be attached to the target protein (Glickman and Ciechanover, 
2002). Additionally, a number of enzymes mediate ubiquitination events by removal of Ub. 
These de-ubiquitinating proteases remove Ub from proteins about to be degraded by the 
proteasome, recycle monomeric Ub from polymeric Ub chains, and edit inappropriately 
ubiquitinated proteins (Wilkinson, 1997; Chung and Baek, 1999; Ehlers, 2004). 
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1.5.4.1 The UPS and axonal injury 
Axonal degeneration in both the CNS and PNS occurs in many pathological and 
developmental settings (Raff et al., 2002; Coleman and Perry, 2002). Multiple lines of 
genetic evidence demonstrate an intrinsic role of the UPS in axon pruning (Hoopfer et al., 
2008). For example, loss-of-function mutations of the El or proteasome subunits in the 
Drosophila mushroom body neurons during metamorphosis blocked axon pruning (Watts et 
al., 2003). Additional roles of the UPS in axon guidance have also been demonstrated 
(Campbell and Holt, 2001). However, recent studies have also identified the UPS as a 
mediator of Wallerian degeneration. Initial evidence for this came from explanted superior 
cervical ganglion cells with physically transected axons (De Stefano et al., 1998). Under 
normal (untreated) conditions the transected axons would undergo complete degeneration 
within 8-10 hrs. However, when axons were treated with pharmacological inhibitors of the 
UPS or when the de-ubiquitinating enzyme UBP2 was expressed in the transected axons (to 
prevent poly-ubiquitination), these axons survived for 16 hrs or longer. The survival of the 
treated cells was at least partially selective for proteasome-mediated proteolysis, as 
inhibitors of caspases and serine proteases had no neuroprotective effect. A similar 
neuroprotective effect was observed following in vivo ischemic retinal injury in gracile 
axonal dystrophy (gad) mice with an exon deletion for the neuron specific de-
ubiquitinating enzyme ubiquitin carboxy terminal hydrolase-Ll (UCH-Ll) (Zhai et al., 
2003). The gad mice showed reduced ubiquitin induction after light stimuli and ischemia 
and increased expression levels of anti-apoptotic proteins Bcl-2, XTAP and pro-survival 
brain derived neurotrophic factor proteins (Harada et al., 2004). UPS involvement in axon 
degeneration following injury was indicated by the accumulation of ubiquitin-like material 
in rat spinal cord following compression injury of varying degrees. Accumulation of 
immunoreactive ubiquitin material was localized to regions of axon swellings. Tl).is 
accumulation was proposed to reflect a disruption to axonal transport possibly arrested 
anterograde transport (Li and Farooque, 1996). This is supported by evidence of 
disassembly of cytoskeletal proteins, resulting in disrupted axon transport, within axon 
swellings (Price et al., 1998; Erturk et al., 2007; Serbest et al., 2007). Additionally, 
sequestered aggregates of proteins (referred to as aggresomes) are known to be actively 
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transported along microtubules, with redistribution of the IF protein to form a cage 
surrounding the core of aggregated, ubiquitinated protein (Johnston et al., 1998). 
It is therefore likely that the axonal cytoskeleton may be a substrate for ubiquitination and 
UPS degradation. A combination of immunocytochemical and biochemical analysis 
revealed major cytoskeletal fragmentation following in vitro transection (Zhai et al., 2003). 
Specifically, both microtubule and NFs are dissembled as the axons swell, bead up and 
fragment, as seen in early experiments (Finn et al., 2000; Schlaepfer et al., 1984; Wang et 
al., 2001). Application of proteasome inhibitors dramatically slowed the degradation of 
both NFs and microtubules following transection, supporting UPS-mediated events. This is 
further supported by evidence of aberrant accumulations of cytoskeletal-associated proteins 
caused by a defect in the UPS (Yang et al., 2007). Microtubule disruption is the earliest (-4 
hrs) feature of cytoskeletal damage following injury, followed later by NF disassembly (-8-
12 hrs). Microtubule destabilization is also one of the earliest features of Wallerian 
degeneration, and is sufficient to induce axon degeneration in some circumstances (Wang 
et al., 2001), which may indicate that activation of the UPS leads in a linear causative 
fashion to microtubule depolymerisation and subsequent NF degradation before 
degeneration. This may be due to the Uh-dependant degradation of microtubule associated 
proteins or regulatory molecules (Ehlers, 2004). 
1.5.5 Axonal sprouting 
Neuronal injuries due to cortical trauma and stroke results in axonal sprouting in the 
hippocampus and the neocortex (Sutula et al., 1998; Esclapez et al., 1999; Golarai et al., 
2001; Santhakumar et al., 2001; Buckmaster et al., 2002; Marchenko et al., 2004). This 
may provide evidence of an adaptive sequence of alterations aimed at healing and 
remodelling (Stroemer et al., 1998; Carmichael et al., 2001; Carmichael, 2003; Lee et al., 
2004). Although these processes may be involved in regeneration there is also the 
possibility that they may also contribute to pathophysiological processes such as 
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epileptogenesis (Dudek and Spitz, 1997; McKinney et al., 1997; Prince et al., 1997; Prince, 
1999). 
Collateral sprouting during development may provide important insights into the formation 
of regenerative sprouts following trauma. The refinement of neuronal circuitry is regulated 
by the formation of collateral axon branches, sprouting from regions behind the distal 
growth cone (Gallo and Letourneau, 1998; Dent et al., 2004; Tang and Kalil, 2005). The 
sprouting of new motile structures, filopodial and lamellae, from previously quiescent 
regions of a neuron is fundamental to the generation of these collateral axon branches. 
Dynamic reorganization of the cytoskeleton underlies the formation of these motile 
structures (Gallo and Letourneau, 1998; Tang and Kalil, 2005) particularly in regard to 
actin filaments, which are also vital for maintenance of these motile structures. Actin 
dynamics have not only been implicated in the growth of collateral branches but also in 
guidance (Gallo and Letourneau, 1998). The location of collateral sprout formation, at least 
during development, has been attributed to calcium transients (Hutchins and Kalil, 2008). 
Many studies have demonstrated collateral sprout formation following axon transection 
(King et al., 2001; Raineteau and Schwab, 2001; Edgerton and Roy, 2002; Edgerton et al., 
2004; Hagg, 2006; Sananpanich et al., 2007). Indeed, these studies illustrated that plasticity 
in the cortex, sub-cortical nuclei and the spinal cord itself can contribute to functional 
recovery in animal models as well as in humans with spinal cord injury (Raineteau and 
Schwab, 2001; Edgerton and Roy, 2002; Edgerton et al., 2004; Hagg, 2006). However, 
collateral sprouting in the severe axon transection models are not directly translatable to 
DAI, which does not involve immediate axotomy. Accordingly, in non-transectional 
models of axonal injury, collateral sprouting has been reported following stroke and 
ischemic cortical injury (Carmichael et al., 2001; 2002; Carmichael, 2003). Additionally, 
axonal sprouting also is present in partially isolated neocortex, a chronic model of 
posttraumatic epileptogenesis (Salin et al., 1995; Graber and Prince, 2006; Jin et al., 2006). 
On one hand, post-stroke axonal sprouting and axon-growth gene expression are seen in 
rodents, experimental primates and humans and correlate in location and magnitude with 
functional recovery (Carmichael, 2003; Carmichael et al., 2004, 2005; Dancause et al., 
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2005; Li et al., 2005; Li and Carmichael; 2006). Conversely, the recurrent excitatory 
synapses formed by sprouting axons of chronically injured pyramidal neurons in rats, is 
proposed to contribute to epileptogenesis (Wuarin and Dudek, 1996, 2001; Jin et al., 2006). 
Altogether, these studies illustrate that non-transected injured axons are capable of 
regenerative sprouting. It remains to be elucidated whether mechanical injury, without 
immediate axotomy, is capable of inducing axon collateral sprouting. This response may 
reduce functional deficits by enhancing innervation, via collateral sprouting around the 
injury site by spared fibres, following injury (Hagg et al., 2005). However, sprouting may 
not necessarily be beneficial and possibly involved in the genesis of post-traumatic epilepsy 
as discussed above. 
1.6 EXPERIMENTAL MODELS OF TBI 
A diverse range of models has been used in an attempt to replicate human TBI, particularly 
DAI. It is often difficult to reliably reconstruct the events leading to primary and secondary 
lesions of varying severity and regional distribution that constitutes TBI (Blumbergs et al., 
1989a). Animal models have been particularly beneficial in the study of TBI as they allow 
for mechanical input that is quantifiable, subject to manipulation, with the head injuries 
produced under a controlled set of experimental conditions (Finnie and Blumbergs, 2002). 
However, there is no single animal model that can reliably replicate the full spectrum of 
human TBI (Maxwell et al., 1997), and this is due to the differing spatial distribution of 
damaged axons in most models. This concept is also important in the comparison of the 
evolving axonal response to trauma in human and animal models. There is increasing 
evidence to show that the rate of axonal change in small animals is faster than that seen in 
large animals (Maxwell et al., 1997). The most broadly used animal models of TBI have 
been classified by Finnie and Blumbergs (2002) as: 
• Direct brain deformation 
• Impact acceleration models 
• Inertial (non impact) acceleration models 
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1.6.1 In vivo models of TBI 
In viva models have been widely used to try and understand the specific responses of the 
brain to TBI. The advantage of using in vivo models is the ability to asses the damage to the 
brain in a three dimensional manner, as well as observing the interactions between a variety 
of cells present in the brain. In viva models of TBI provide a more accurate representation 
of the processes that occur in humans, as they incorporate the physiological conditions 
found in the brain of a patient with brain injury. Additionally, manipulating cerebral 
perfusion and oxygenation to generate diffuse ischemia may be useful to differentiate the 
neuropathological features of global ischemia from DAI (Povlishock et al., 2005) aiding in 
the design of targeted therapeutic interventions (Saatman et al., 2008). 
Most in viva models involve the application of a mechanical force to the head of an animal, 
followed by a recovery period, and the removal of the brain in order to observe any 
damage. The most common in viva model used in the early studies of TBI is the impact 
acceleration model. This has been used in primates (Gennarelli et al., 1982; Maxwell et al., 
1993), sheep (Finnie et al., 2000; Finnie et al., 2001; Finnie et al., 2002), rats (Bakay et al., 
1977; Marmarou and Shima, 1990) and cats (Tornheim et al., 1984; Tomheim et al., 1990). 
Impact acceleration models typically involve direct impact to the brain using a piston, a 
humane stunner or captive bolt, a calibrated pendulum, or a weight drop onto the skull 
(Finnie and Blumbergs, 2002). These models replicate closed head injury commonly 
associated with falls, assaults and motor vehicle accidents, which involve the rapid 
movement of the brain within the skull following impact. The main disadvantage with this 
model is that it sometimes fails to produce a highly repeatable injury (Finnie and 
Blumbergs, 2002). 
Inertial acceleration models involve rapid acceleration and deceleration of the head without 
impact. These models induce a repeatable pathologic response, especially when the 
direction and distance of the head is constrained. Many features of human TBI has been 
reproduced in this model, including coma and DAI in the white matter (Ommaya and 
Gennerarelli, 1974; Gennerarelli and Thibault, 1982; Gennerarelli et al., 1982,1990), 
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however, unlike most human motor accidents it does not involve impact. In this model of 
head trauma the acceleration required to produce injury experimentally is found only in 
human TBI when impact occurs (Lighthall et al., 1989). 
In recent years, direct brain deformation models, particularly involving fluid percussion, 
have become the most common model of TBI. These models usually involve a fluid pulse 
to rapidly compress the exposed dura or cortex through a craniotomy site (Chytrova et al., 
2008; Marmarou et al., 2005, 2006). Indeed, fluid percussion models have been 
implemented in the study of injury pathology (Erb and Povlishock, 1988; Conti et al., 
1998), physiology (Mcintosh et al., 1994;Albensi et al., 2000), and pharmacology (Faden et 
al., 1989; Faden et al., 2003) in a wide range of species including, rats (Dixon et al., 1988; 
Faden et al., 2003), mice (Carbonell et al., 1999), cats (Zauner et al., 2002), pigs (Gibson et 
al., 2002), rabbits (Hartl et al., 1997) and sheep (Millen et al., 1985). These types of injury 
generally provide reproducible levels of localized damage to cortex and the brain stem 
(Cernak, 2005). Additionally, alterations in cerebral blood flow and increased permeability 
of the blood-brain barrier have been illustrated in these models (Muir et al., 1992; Tanno et 
al., 1992; Schmidt and Grady, 1993; Qian et al., 1996). The lateral fluid percussion model 
provides an injury that replicates clinical contusion without skull fracture, and shows a 
direct relationship between the majority of pathological alterations and injury severity 
(Cernak, 2005). As a result, direct brain deformation models are widely used in mechanistic 
studies and for drug screening (Cernak, 2005). The limitations of in viva direct brain injury 
models is the increased levels of injury severity, which often results in mortality due to 
large amounts of damage to the brainstem. 
The difficulty in using in viva models is that the total amount of axonal injury in the brain 
may be the result of a combination of mechanical and ischemic injury, it is therefore 
mandatory for continuous physiological monitoring to ensure that there is no complicating 
hypoxic episodes that supervene, as there are no current histological methods for 
distinguishing between the different types of injuries. Injured axons have also been shown 
to be more vulnerable to ischemia than uninjured axons (Fehlings et al., 1989). 
Additionally, although all the in vivo models integrate different methods of applying 
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mechanical force to the brain, each one of them basically induces localized morphological 
alterations. As a result of limited diffuse injuries, the majority of these models do not cause 
significant long-term deficits that would be of importance to clinical TBI (Cernak, 2005). 
Accordingly, these models are more helpful in studies investigating the pathophysiology of 
localized contusions and/or for the control of treatments aimed at reducing the size of focal 
lesions (Lighthall et al., 1989). 
1.6.2 In vitro models of TBI 
Although the diverse range of in vivo models of DAI have yielded encouraging results in 
the laboratory, these have largely failed to translate effectively into humans. As a result, 
another approach has been to further develop newer supplementary methodologies to 
explore the mechanisms underlying DAI and subsequently develop hypothesis-based 
strategies on in vivo models (Kumaria and Tolias, 2008). In this regard, although in vitro 
models are simplified platforms in the investigation of DAI, they are able to complement in 
vivo models them and allow the exploration of different aspects. Accordingly, in vitro 
models are advantageous as there is better control over experimental variables, they are 
cheaper and easier to use, and there are fewer ethical issues (Kumaria and Tolias, 2008). 
Additionally, in the study of the milder forms of DAI, where there is no immediate cellular 
damage, it is easier to monitor the consequences of mechanical injury to a particular cell 
type using in vitro models, and also increase the screening of therapeutic agents (Morrison 
et al., 1998a). 
One of the earliest and still widely used in vitro models of DAI is the axon transection 
model (for in vivo models see pioneering work of Cajal et al., 1928). Typically, in more 
recent studies, these models involve the culturing of neurons (with or without glia) on to 
substrate coated substrates, and transection of the cultured axons using a scalpel (King et 
al., 1997; Dickson et al., 1999, 2000, 2005; Vickers et al., 2000; Chuckowree and Vickers, 
2003; Haas et al., 2004; Blizzard et al., 2007). These models of axonal injury are reflective 
of penetrating brain injuries and are useful also for investigating the regenerative sprouting 
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response (Chuckcowree and Vickers, 2003; Chuckcowree et al., 2003, 2004; Haas et al., 
2004; Blizzard et al., 2007), and the pathology underlying Alzheimer's disease (King et al., 
1997; Vickers et al., 2000). The advantages of these types of models are that they are less 
expensive, and require less skill, thereby making them more amenable to the study of 
multiple novel therapeutic agents. A disadvantage of axon transection models is that 
generally they do not account for mechanical stimuli that might relate more closely to DAI 
such as force, strain and strain rate (Morrison et al., 1998b). However, probably the largest 
drawback of these models is that primary axotomy only occurs at the most severe levels of 
injury and may not be yielding to intervention as delayed secondary axotomy in vivo 
(Povlishock and Christman, 1995), resulting in a less clinically translatable concept 
(Kumaria and Tolias, 2008). Extending on these studies, other in vitro models have utilised 
compression injuries to cell cultures (Murphy and Horrocks, 1993) or organotypic brain 
slices (van de Pol et al., 1990; Sieg et al., 1999), similar to that seen in in vivo spinal cord 
injury models (Ballentine et al., 1988). However, it is often difficult to reliably measure 
strain field at the site of impact (Morrison et al., 1998b). 
As discussed previously, shear forces created by inertial loading of the brain are manifest 
during DAI or contusion (Sahuquillo and Poca, 2002). In an attempt to model these forces, 
cultured neurons and glia were subjected to three tangential accelerations over 3-5 second 
time intervals (Lucas and Wolf, 1991). However, in this model, deflection of the axon was 
not measured directly (Kumaria and Tolias, 2008). Building on this study, Nakayama and 
colleagues (2001) designed an in vitro model that involved the oscillation of cells in a 
single plain over a varied amount of time. Although the injured cells could be directly 
observed by light microscopy, the hydrostatic pressures involved in this type of model 
would be difficult to translate to an in vivo or clinical setting. 
A major disadvantage of all the models of DAI detailed above is that they do not portray 
the current understanding of the pathophysiology of TBI. In this regard, axonal injury is 
proposed to be an initiator of cellular cascades that ultimately result in a delayed secondary 
neuronal death. Accordingly, sublethal neuronal injury is increasingly appreciated as an 
important target in the investigation of interventions to prevent the ensuing secondary cell 
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death. Currently, models of axonal stretch injury are regarded as the gold standard in the 
study of the post-injury sequelae following DAI (Kumaria and Tolias, 2008). The first 
axonal stretch injury model was developed by Cargill and Thibault and involved the 
culturing of NG 108-15 neuroblastoma cross-glioma cells on custom-built wells, which 
were deformed with a vacuum pulse generating strains as high as 0 .45 with strain rates 
between <1 and 10/sec (Cargill and Thibault, 1996). Further developments to this model 
resulted in strains up to 0.65 at strain rates between 0.04 and 15/sec (Morrison et al., 
1998b). However, probably the best-characterized and most widely used model of axonal 
stretch injury is that designed by Smith and colleagues (1999). In this model, neurons 
derived from a N-Tera2 cell line were cultured on a deformable substrate, which was then 
stretched using an air-pulse generating system (Smith et al., 1999). The strains achieved by 
this model were in the range of 0.58 - 0.77 and applied to the axon at times between 26 and 
35/sec. Importantly, this model was not only the first to report the thresholds for primary 
axotomy, but also induce a sublethal mechanical strain that allowed investigation of the 
acute temporal evolution of axonal alterations in response to injury (Smith et al., 1999). 
The axonal stretch injury model produced by Smith and colleagues has been widely used to 
demonstrate a number of novel findings. These include the high tolerance of axons to 
stretch injury, and no overt alterations to axolemma permeability unless there is axotomy 
(Smith et al., 1999). Additionally, this model was utilised to illustrate that traumatic 
deformation of axons induces abnormal sodium influx through mechanically sensitive 
sodium channels, which subsequently triggers an increase in intra-axonal calcium via the 
opening voltage-gated calcium channels and the proteolytic cleavage of voltage-gated 
sodium channels (Wolf et al., 2005; Iwata et al., 2004). These studies have highlighted the 
possible therapeutic potential of agents like tetrodotoxin and protease inhibitors (Iwata et 
al., 2004). Another interesting caveat derived from results of this model is the new 
approach to nervous system repair, which involves the development of transplantable 
nervous tissue constructs comprised of mechanically stretch-grown axons (Pfister et al., 
2006). Over recent years, axonal stretch injury models have characterized stretch in three 
dimensions, a variable that adds further credence to the clinical scenario (LaPlaca et al., 
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2005). Interestingly, these models have reported that biaxial stretch injury induced more 
damage compared to uniaxial stretch injury (Geddes-Klein et al., 2006). 
In summary, the majority of in vitro stretch injury models, yet not inducing primary 
axotomy, still simulate more severe levels of injury (Kumaria and Tolias, 2008). Regarding 
the findings mentioned above, it appears that milder forms of injury are more realistic 
targets for intervention at the present time. Indeed, the delayed nature of secondary 
axotomy provides an ideal opportunity for therapeutic intervention. 
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1.7 PROJECT AIMS 
One of the greatest clinical challenges in the field of neurotrauma is the minimization of 
secondary neuronal damage following TBI. Currently, there are no successful treatment 
strategies for DAI, despite positive therapeutic outcomes in animal models of head injury. 
In this regard, in vivo DAI models, to date, have revealed encouraging results that have 
failed to be translated into a clinical setting. Over recent years, a new approach has been to 
utilise in vitro models of DAI to characterise specific pathophysiological mechanisms, 
providing better-defined hypotheses to be tested in vivo, which are more likely to 
subsequently translate into future neuroprotective therapies. Furthermore, previous studies 
have illustrated that milder forms of TBI, which is the predominate form of head trauma 
(Povlishock and Christman, 1995), are more realistic targets for intervention due to the 
increased vulnerability of diffusely (unsevered) injured neurons and that the death of these 
neurons constitutes most or all of secondary injury (Smith et al., 2003; Buki and 
Povlishock, 2006). Indeed, DAI is an evolving form of axonopathy, developing over an 
extend period of time, which provides an opportunity for therapeutic interventions aimed at 
impeding the cellular alterations that lead to secondary degeneration (Buki and Povlishock, 
2006). 
Current in vitro axonal stretch injury models have provided important mechanistic insights 
into the axonal response to severe shear/strain injury, however, little is known about the 
response of axons to milder forms of stretch injury. Additionally, it is often difficult to 
locate and image mildly injured axons in vitro, as there is no immediate significant damage 
to the cell. The development of a primary cortical cell culture technique that results in the 
formation of neuronal cell clusters interconnected by long axonal bundles has provided an 
ideal platform to image and characterise the response of particular axons to injury (Dickson 
et al., 1999; Chuckowree et al., 2003; Blizzard et al., 2007). Therefore, this thesis will 
implement this primary cortical cell culture technique to investigate the important 
mechanistic insights underlying DAI, utilising a novel animal model capable of replicating 
the mechanical forces involved in mild to moderate DAI. 
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AIMl 
To develop a novel in vitro model of mild to moderate axonal injury capable of delayed 
secondary axotomy. 
The majority of animal models of axonal injury involve higher levels of mechanical trauma 
often resulting in either immediate substantial axotomy or the rapid severing of the axon 
within one hour. As the majority of human TBI cases do not involve immediate axotomy at 
the time of injury, rather the activation of cellular and pathological cascades resulting in 
delayed axotomy, less severe models of axonal injury need to be investigated. To achieve 
this aim a novel in vitro axonal injury was developed. This model of axonal injury utilises 
neocortical neurons from rat embryos that are grown in culture to relative maturity. The 
growth conditions of this system promote neuronal aggregation and axonal bundle 
formation, which will be the site of acute stretch injury. To characterise the axonal response 
to injury, the injured axon bundles will be fixed at predetermined time-points and analysed 
using immunocytochemical techniques to determine if there is secondary axotomy. 
AIM2 
To investigate the neuronal response to mild-moderate axonal stretch injury, specifically, 
characterising the progressive cellular alterations prior to secondary axotomy. 
There has been no comprehensive study that has characterised the sequence of events that 
precede secondary axotomy following mild to moderate axonal injury. In this regard, the 
mechanical trauma does not induce any immediately detectable axonal change and may 
rather result in subtle changes to the axon cytoskeleton. Therefore, immunocytochemistry 
will be utilised to determine the cytoskeletal alterations from the moment of injury, up to 
secondary axotomy. To further investigate the underlying cause of cytoskeletal damage 
following injury, the integrity of the axolemma will be assessed, using cell impermeant 
tracers, to determine whether alterations to the axolemma permeability is linked to the 
axonal damage following trauma. Calcium imaging techniques will also be utilised to 
establish if intra-cellular calcium alterations play a role in post-injury sequelae. 
AIM3 
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To investigate the mechanisms of axonal degeneration associated with secondary 
axotomy and possible therapeutic interventions. 
Recently, the activity of the UPS and calcium-dependant pro-apoptotic pathways, which 
include release of cytochrome-C and the activation of calcineurin, has been implicated in 
axonal degeneration following primary axotomy. Calcium induced release of cytochrome-C 
from mitochondrial stores has been linked with the activation of caspases and calpains, 
which may be responsible for the degradation of the cytoskeleton prior to secondary 
axotomy. Additionally, inhibition of the UPS has been shown to delay Wallerian 
degeneration following the transection of axons. These two degenerative pathways may 
provide insight into the mechanisms involved in the delayed secondary axotomy. 
Therefore, immunocytochemical techniques will be utilised to investigate whether there is 
activation of the UPS or release of cytochrome-C from mitochondrial stores. Additionally, 
pharmacological inhibitors of UPS function and the MPT pore, which is involved in the 
release of cytochrome-C, will be examined to determine the role of these two pathways in 
the induction of secondary axotomy. Pharmacological inhibition of calcineurin will also be 
utilised to demonstrate whether this calcium-activated phosphatase plays a role in the 
degradation of the cytoskeleton following injury. 
AIM4 
To investigate the regenerative capacity of axons following non-severing axonal stretch 
injury. 
It is proposed that loss of synaptic connectivity (deafferentation) following DAI, sets the 
stage for subsequent neuroplastic alterations that can lead to either adaptive or maladaptive 
changes (Buki and Povlishock, 2006). This has been difficult to study not only because 
neuroplasticity is complex to follow in the human brain, but also because this is difficult to 
replicate in an experimental setting. There is limited data that suggests that in the case of 
severe in vivo TBI, where there is axon severance, diffuse deafferentation initiates 
sprouting of adjacent intact nerve fibres that in some cases leads to the recovery of 
significant synaptic input to the previously deafferentated neuronal domains (Erb and 
Povlishock, 1991). Indeed, the generation of post-traumatic epilepsy, which is seen 
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following moderate to severe TBI, has been linked to aberrant axonal sprouting (Benardo, 
2002). It is unclear whether mechanically injured neurons can initiate an axonal sprouting 
response, without primary or secondary axotomy. Therefore, the axonal sprouting response 
of mildly stretch injured axons will be determined using live-imaging. To accomplish this 
aim, injured axons will be loaded with a lipophillic cell tracer dye (Dil), at set time-points 
prior to secondary axotomy and imaged using a fluorescent microscope. 
Immunocytochemical labelling will also be used to illustrate the cytoskeletal composition 
of these axonal sprouts and determine whether they contain growth-associated proteins 
(GAP43). Additionally, scanning electron microscopy will be utilized to determine if 
axonal sprouts have growth cone-like guidance structures, which are important for 
controlled axon growth (Blizzard et ·al., 2007). Using inhibitors of actin dynamics and 
calcineurin, latrunculin-A and FK506 respectively, the role of actin reorganization and 
calcium signalling pathways in the post-injury sprouting response will be determined. 
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2 MATERIALS AND METHODS 
2.1 CELL CULTURE 
Time-mated Hooded-Wistar rats caITying pups of 18 days gestation (El8 with sperm-
positive day = El) were sacrificed by carbon dioxide exposure, in accordance with the 
guidelines stipulated by the University of Tasmania Animal Ethics Committee. Rat pups 
were immediately removed, placed on ice and decapitated. The cortex was exposed using 
fine scissors, the meninges pulled away and tissue dissected from the neocortical region 
using fine forceps and collected in 5 ml of 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) buffer (Sigma), at 37°C. Enzymatic digestion 
was carried out with 0.025% trypsin for 15 minutes at 37°C. Tissue was washed three times 
with HEPES and mechanically dissociated using a pipette. Staining with trypan blue 
(Sigma) was used to assess cell viability and concentration. Cells were then plated onto 
glass coverslips (132 mm2) pre-coated overnight with 0.01 % poly-L-lysine, at a cell density 
of 5 x 104 cells/well. Cultures were maintained at 37°C in humidified air containing 5% 
C02. Neurons were initially plated into a culture medium consisting of Neurobasarri.1 
medium, 2% B27 supplement (Gibco), 10% foetal calf serum (Gibco), 0.5 mM glutamine, 
25 µM glutamate and 1 % antibiotic/antimycotic (Gibco ). At 24 hrs post-plating, the media 
was replaced with similar media, but with no fetal bovine semm. Culture media was 
replaced every 3 days. The fresh medium contained factors that inhibited substantial glial 
cell proliferation (Chuckowree and Vickers, 2003). As initially reported (Dickson et al., 
2000; Chuckowree and Vickers, 2003), this long-term culture technique results in the 
formation of large neuronal clusters across the coverslip interconnected by thick 
fasciculated axonal bundles (Fig. 2.1). These axonal bundles form synapses, and contain a 
cytoskeletal architecture characteristic of mature axons (Chuckowree and Vickers, 2003). 
2.2 AXONAL STRETCH INJURY 
At 20 days in vitro (DIV), a single coverslip was placed into an individual 35-mm tissue 
culture (Petri) dish with 2 ml of fresh culture media. The next day, the culture dish was 
placed upon a Leica DMIL inverted microscope. The tip of a glass micropipette (bore 
thickness 5-10 pm; obtained from P-97 flaming micropippete puller with programmable 
38 
Figure 2.1 Neuronal cultures at 21 days in vitro had formed large clusters, 
interconnected by fasciculated bundles of axons (indicated by arrows), shown by bright-
field microscopy (A), immunocytochemical neurofilament labelling (B), and scanning 
electron microscopy (C).Note the highly organized arrangement of parallel 
neurofilament-immunoreactive processes within the axonal bundle (B).Scale bar, 10 µm 
(A,B), 20 µm (C). 

microprocessor controller, Sutter Instrurµents) was submerged into the media and moved 
until just touching the surface of the axon bundle, retracted 100 µm, and a single pulse of 
media was applied at 20 psi over a period of 13-20 msec using the Picospritzer III (Parker 
Instrumentation). This resulted in a deflection of a localized segment of the axonal bundle. 
with the axon bundle responding like a rubberband, such that after stretching it returned 
back to its original position. A digital movie covering the axonal deflection was captured 
using an Ikegami (ICD46E) video camera (for an example see Supplementary Movie 1). 
Only deflections resulting in a relatively minor stretch of 1-6% increase in original axon 
length are reported. lt is notable that deflections of this magnitude did not result in primary 




Neuronal cultures were fixed using a solution of 4% paraformaldehyde (PFA, Sigma)/4% 
sucrose (Sigma) in 0.1 M phosphate buffer for 30 minutes at room temperature. Fixation 
was followed by three ten minute O.OlM PBS washes, prior to immunocytochemistry. 
Table 2.1 shows commonly used primary antibodies. 
2.3.2 Indirect fluorescence immunocytochemistry 
Following fixation, primary antibodies, which recognise and bind to specific epitopes of 
cellular proteins, were applied to specimens at appropriate concentrations (Table 2.1), 
diluted in a 0.3% Triton-X (Fluka) solution, which was used to permeabilise cell 
membranes. Optimum antibody concentrations were individually determined for each 
antibody and control experiments, omitting primary antibodies, eliminated all 
immunoreactivity. Primary antibodies were incubated on an orbital shaker for two hours at 
room temperature, then overnight at 4°C, followed by three O.OlM PBS washes. Species 
and isotype specific AlexaFluor fluorescent secondary antibodies (Table 2.2) were applied 
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Table 2.1 Primary antibodies 
Antigen Fixation Cell Type and Source Immunising agent 
method culture 
dilution 
Alpha-intemexin 4%PFA 1:1,000 M Full length 
(Clone 2F3) recombinant rat 
Chemicon alpha-internexin 
Alpha-internexin 4%PFA 1:5,000 R Full length 
Novus recombinant rat 
Biologicals alpha-internexin 
Beta-III Tubulin 4%PFA 1:10,000 M C terminus ~-III 
(neuron specific) (Clone 5G8) tubulin (EAQGPK) 
Promega 
CDllb/c 4%PFA 1:100 M Rat glial 
(Clone CE-1) membranes and 
CalTag whole brain white 
matter 
Cytochrome c 4%PFA 1:1,000 M Rat cytochrome c 
(Clone 6H2.B4) 
BD Biosciences 
Ferri tin 4%PFA 1: 1,000 R Ferri tin from 
(activated Dako human liver 
microglia) 
Growth-associatted 4%PFA 1: 1,000 M GAP43from 
protein-43 (Clone GAP- neonatal rat 
(GAP43) 7B10) forebrain 
Sigma membranes 
Glial fibrillary 4%PFA 1: 1,000 M Purified GFAP 
acidic protein (Clone 6F2) from porcine spinal 
(GFAP) Chemicon cord 
Glial fibrillary 4%PFA 1:5,000 R GFAPfromcow 
acidic protein Dako spinal cord 
(GFAP) 
NFH 4%PFA 1:1,000 R Purified bovine 
Serotec neurofilament 
proteins 
NFL 4%PFA 1:1,000 R Native NFL 
Novus purified from pig 
Biologicals spinal cord 
NFM 4%PFA 1:1,000 R Purified primate 
Serotec neurofilament 
proteins 
NFM/NFH 4%PFA 1:2,000 M Hypothalamus 
dephosphorylated (Clone SMI32) 
(SMI32) Sternberger 
NFM/NFH 4%PFA 1:10,000 M Hypothalamus 
phosphorylated (Clone SMI312) 
(SMI312) Sternberger 
Antigen Fixation Cell Type and Source Immunising agent 
method culture 
dilution 
Spectrin (neuron- 4%PFA 1: 1,000 R synaptic/axonal 
specific) Chemicon membranes from 
perfused mouse 
brain. 




Tau 4%PFA 1:20,000 R C-terminal human 
Dako tau 
Ubiquitin 4%PFA 1: 1,000 R Ubiquitin from cow 
Dako erythrocytes 
M, Mouse monoclonal; R, Rabbit polyclonal 
Table 2.2 Secondary antibodies 
Emission Reactivity Species Supplier 
488 Mouse Goat Molecular Probes 
IgG 
594 Mouse Goat Molecular Probes 
lgG 
488 Rabbit Goat Molecular Probes 
lgM 
594 Rabbit Goat Molecular Probes 
IgM 
488 Rabbit Goat Molecular Probes 
594 Rabbit Goat Molecular Probes 
at a dilution of 1: 1000 and incubated in the dark, on an orbital shaker for 90 mins at room 
temperature. Secondary antibodies were removed and cells were stained with 0.0001 % 
nuclear yellow (Molecular Probes) in PBS for 20 mins at room temperature in the dark. 
Cells were washed three times with PBS, followed by rinsing in MilliQ® and mounting 
onto microscope slides using Permafluor mounting medium (Beckman Coulter). 
2.4 MICROSCOPY AND ANALYSIS 
Fluorescent immunolabelled slides were examined usmg a Leica DMLB2 
immunofluorescence microscopevequipped with a cooled CCD Magnafire (Optronics) 
/ 
digital camera. Images were acquired with Magnafire (version 1.0) software, and figures 
prepared using Adobe Photoshop® (version 7.0) where necessary. For analyses images 
were acquired at identical exposure settings and adjusted in an identical manner. 
Subsequent analysis was performed with the aid of NIH lmageJ (version l.33u). Graphs 
and statistical analyses were performed with Graphpad Prism4® software or Microsoft 
Excel (Mac Os X). For statistical analyses data was obtained from at least three separate 
cultures and means are reported ± standard error of the mean (SEM). P values were 
determined using either one-way or two-way ANOV As (Graphpad Prism4® software) with 
a value less than 0.05 were considered statistically significant. 
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3 MILD AXONAL STRETCH INJURY IN VITRO INDUCES A PROGRESSIVE 
SERIES OF NEUROFILAMENT ALTERATIONS ULTIMATELY LEADING 
TO DELAYED AXOTOMY 
3.1 INTRODUCTION 
Diffuse axonal injury typically results in a series of subtle axonal abnormalities, which 
progressively develop over a period of time, ultimately leading to delayed axonal 
disconnection and degeneration (Maxwell et al., 2003). DAI is considered an important 
pathological neuronal alteration linked to clinical outcomes following TBI (Povlishock, 
1992: Maxwell and Graham, 1997; Smith and Meaney, 2001). In an attempt to identify the 
sequelae of axonal alterations in response to DAI, researchers have developed animal 
models to experimentally induce mechanical axonal stretch or compression injuries 
(Balentine et al., 1988; Smith et al., 1999: LaPlacca et al .. 2005). These studies have 
yielded considerable insight regarding axonal alterations in response to DAI, and illustrate 
the advantages of in vitro models in the overall elucidation of the entire sequence of 
pathological axonal changes prior to secondary degeneration. 
Although bearing the limitation of being limited to a largely two-dimensional environment, 
in vitro models of TBI have also provided some valuable insight into axonal alterations in 
response to in jury. Such models include direct physical transection of the axon (Dickson et 
al., 2000; Chuckowree et al., 2003), mechanical stretching of axons of a neuronal cell line 
NTera2 (Smith et al., 1999) or of primary cortical neurons (Iwata et al., 2004), and physical 
oscillation of neurons in a single plane over a short period of time (Nakayama et al., 2001). 
A significant advantage of in vitro models is the ability to observe the progression of 
axonal alterations of individual axons over a period of time, and to test the effect of 
therapeutic agents directly upon injured neurons. 
The studies described above utilise in vitro models of injury that result in relatively severe 
axonal injury and, as a consequence. usually result in axotomy within 24 hrs, which in a 
comparative sense is likely to be indicative of only the most severe cases of head trauma. In 
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the current study a novel model of transient axonal stretch injury involving pressurized 
fluid deflection of axons was developed in order to improve understanding of the sequelae 
of events in response to mild axonal trauma. Similar models of transient axonal stretch 
injury have been reported previously, which have determined that the tensile threshold for 
axotomy within 24 hrs lies at a 15-65% increase in original axon length (Smith et al., 
1999). It is important to note that these models involve stretching of a long segment of the 
axon (typically greater than 100 ;tm). The current model involves subjecting axons of 
neurons matured in long-term culture to significantly milder tensile strain across a small 
axonal length (less than 100 µm), ranging from a 1 % to a 6% increase in original axon 
length. To assess the progression of axonal changes following this relatively mild form of 
DAI, cytoskeletal changes were examined using immunocytochemical techniques over a 
period of 72 hrs. 
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3.2 MATERIALS AND METHODS 
3.2.1 Cortical neuron cultures and experimental axonal deflection 
Neuron cultures were prepared according to the procedures outlined in chapter 2.1.l 
(Materials and Methods). Axonal bundles ranging from 10 to 16 Jtm in diameter were 
selected. In vitro stretch injuries were performed as described in chapter 2.2 (Materials and 
Methods; for an example, see Fig. 3.1; see also Supplementary Movie 1). For this study, a 
total of 175 injuries were perfmmed over five different neuronal cultures. 
3.2.2 Measuring the Degree of Axonal Deflection 
By capturing digital movies of the deflection event. it was possible to measure the degree of 
axonal stretching. This was performed for all of the axonal bundles that were injured during 
the course of this study. To do this. the digital movie was expanded to all of the individual 
frames (using NIH Image), and the frame displaying the maximal axonal deflection 
selected. Using this frame, the maximal length of the stretched axon bundle was measured 
(using NIH image), and the tensile strain applied was calculated as the percentage increase 
in axonal bundle length compared to the original length of the axon bundle. In all cases, 
axonal bundles were measured along their entire length, from one cellular cluster to the 
next. Stretch injuries of 1-20% were attainable. 
3.2.3 Fluorescent immunocytochemical analysis of cytoskeletal changes in response 
to axonal deflection 
Fixation and immunocytochemistry was performed using the standard procedures in 
chapter 2.3 (Materials and Methods). Stretch injured axon bundles were fixed at 24 hrs, 48 
hrs and 72 hrs PI and immunolabelled with antibodies targeting phosphorylated 
neurofilaments (SMI-312) It has previously been shown that SMI312 immunoreactivity 
43 
does not co-localize with MAP-2 labelled dendrites in this model (Chuckowree and 
Vickers, 2003), indicating that the SMI312 antibody cocktail identifies axons primarily. 
Indeed, in this culture system, we have reported previously that there are almost no MAP2-
positive dendrites within the fasciculated axonal bundles that were injured in this study 
(Chuckowree and Vickers, 2003). 
3.2.4 Three-dimensional reconstruction of injured axonal bundles 
In some circumstances (approximately 20% of all injured cultures, chosen at random) 
following immunofluorescent labelling, rather than coverslips being mounted onto glass 
slides. coverslips were placed cell-side up into a glass Petri dish immersed with PBS and 
observed on an inverted fluorescent stereomicroscope (Leica DMIRB). For three-
dimensional (3-D) reconstruction, a series of digital images were captured at 2-µm z-axis 
intervals (Optronics Magnafire digital camera) through the entire thickness of the injured 
axonal bundle (ranging from 10 to 50 Jim), and the entire stack of images underwent 3-D 
restoration under a nearest-neighbour algorithm using OpenLabTM software (Improvision). 
To clearly visualize immunocytochemically labelled cytoskeletal features within the injured 
axonal bundle, the 3-D reconstructed stack of images was compiled and then rotated in the 
x- and y-axis using the 3-D rende1ing tool within OpenLab rn, and the resultant data 
presented in QuickTimeTM movie format. 
44 
Figure 3.1 An individual axon bundle was targeted with a single pulse, and the resultant 
deflection was captured by video camera. In the selected series of frames (A-C), the 
axon bundle is rapidly stretched, before recovering to its original position (indicated by 
dashed red line). For reference, a diagrammatic representation of the injury is also 














3.3.1 Characterizing the temporal sequence of cytoskeletal alterations in response to 
mild axonal stretch injury 
Post-fixation immunocytochemical analysis demonstrated that, by 24 hrs PI, there was no 
discernable difference between stretched and unstretched axonal bundles; stretched axons 
r~mained smooth in profile and axons maintained an ordered arrangement within a 
relatively straight bundle fmmation (Table 3.1). However, by 48 hrs PI, NF 
immunoreactivity was consistently higher in injured axon bundles compared to stmounding 
uninjured axon bundles (51 % of all stretched axonal bundles displayed increased NF 
immunoreactivity; Table 3.1, Fig. 3.2A,B). Furthermore, at the site of stretch injury, some 
axonal bundles (25%; Table 3.1) lost their ordered arrangement, with individual axons 
segregating from each other, often resulting in a frayed appearance of the bundle (Fig. 
3.2C). However, it is important to note that individual axons did not appear to be 
axotomised, rather they became distorted, appearing undulating and wavy within a highly 
localized region that conelated with the stretched region of the axon (Fig. 3.2C). Small 
ring-like NF structures were observed within the frayed region of a minority (7%; Table 
3 .1, Fig. 3 .2D) of axon bundles by 48 hrs Pl. By 72 h PI, increased NF staining was less 
evident (in only 27% of cases; Table 3.1), but segregation of individual axons within the 
bundle was more pronounced, and at higher magnification many axons within the bundle 
were found to be completely disconnected (axotomy was observed in 70% of cases; Table 
3.1, Fig. 3.2E). At this time. ring-like NF structures were present within the frayed region 
of the bundle (30% of axonal bundles; Table 3.1), often appearing to be located at the 
terminating tip of injured axons (Fig. 3.2F). These results clearly demonstrate the temporal 
progression of axonal changes in response to stretch injury, from increased NF 
immunoreactivity to severe alterations such as delayed axotomy. Note that the SMl312 
antibody used to identify NF proteins non-specifically binds to nuclei, as reported 
previously (Chuckowree and Vickers, 2003). Given that the same fluid pressure (20 psi) 
was applied for all injuries, it is likely that the individual injury level will vary depending 
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Figure 3.2 Neurofilament immunoreactivity in stretched axon bundles was significantly 
increased in comparison to uninjured axons at 48 hrs PI (A, enlarged in panel B; 
indicated by arrowhead). At this time, axon bundles regularly became disorganized at 
the site of injury, with individual processes separating from each other and becoming 
wavy along a segment of their length (C; indicated by arrowhead). Occasionally, ring-
like neurofilament structures were observed within the site of stretch injury (D; indicated 
by arrow). By 72 hrs PI, a number of those axons that had been stretched became 
completely disconnected (E; indicated by arrowhead), and a greater number of ring-like 
neurofilament structures were present (F; indicated by arrows). Note that the SMI312 
antibody, used for neurofilament labeling, non-specifically binds to nuclei, which is 
apparent in these images. Scale bar 15µm. 
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Table 3.1 A number of different axonal bundles ranging in thickness from 10 to 16 µm in thickness were 
deflected, resulting in an increase in original axon length of 1-6%, and assessed at either 24, 48, or 72 hrs post-
injury (PI) for the presence or absence of cytoskeletal alterations in neurofilament (NF) protein distribution. 
These results are presented as percentages, with the actual number of injured axon bundles displaying a 
cytoskeletal abnormality recorded in brackets. The time-point at which 
each characteristic cytoskeletal alteration was observed the most is shaded. 
Table 3.2 Increased neurofilament immunoreactivity 
10 c+ 




Table 3.3 Axonal distortion 
._ h PI 
2% 
2 ~PI 
A number of different axonal bundles ranging in thickness from 10 to 16 
µm in thickness were exposed to the same fluid pressure (20 psi). The 
increase in original axon length of each axonal bundle was measured and 
assessed at either 24, 48, or 72 hrs post-injury (PI) for the presence or 
absence of cytoskeletal alterations in neurofilament protein distribution, 
namely increased neurofilament immunoreactivity (Table 3.2), axonal 
distortion (Table 3.3), and the presence of ring-like neurofilament 
immuno-reactive structures (Table 3.4). These results are presented as 
percentages, with the time-point at which each characteristic cytoskeletal 
alteration was observed the most highlighted (lighter highlighting 
represents less than 50% occurrence; darker highlighting greater than 
50% occurrence). Note that this table is derived from the same 
experimental data as Table 3.1 , however extra data from higher intensity 
stimulus (106%+) is also included. 
on the length of the injured axons. To account for this, the actual degree of axonal 
deflection was calculated for each injured axonal bundle (from the same experimental 
samples discussed above), and the same morphological parameters of axonal injury applied 
above were used for analysis. In the case of increased NF immunoreactivity, this was most 
apparent at 48 hrs PI for all degrees of injury strain (Table 3.2), and particularly at the 100-
103% and 103-106% levels of strain. For injuries of 106% and higher, there was a much 
lower number of axons displaying this morphology, since a number of the axon bundles 
had become axotomised at this time. Similarly, the number of axons displaying increased 
NF inununoreac..:tivity was dramatically lower by 72 hrs PI, since the majority of axons had 
undergone secondary axotomy by this time (Table 3.1). In the case of axonal distortion, this 
was most apparent at the higher strain levels (>103%) and at longer times PI (Table 3.3). 
Interestingly, the presence of ring-like NF immunoreactive structures was most apparent at 
the mildest strain level, and became more evident at 72 hrs PI (Table 3.4). Indeed at greater 
strain levels there was very little development of these ring-like structures, even at time-
points up to 72 hrs PI. 
3.3.2 Three-dimensional reconstruction of injured axonal bundles 
3-D reconstruction was performed by compiling a series of digital images captured at 2µm 
z-axis intervals through the entire thickness of an injured axonal bundle at 48 hrs PI (some 
of these images captured at different z-axis depths are presented in Fig. 3.3A). The entire 
stack of images was compiled into a single, "flattened" image representing a 3-D "looking 
down" view through the entire axonal bundle (Fig. 3.3B). Following 3-D reconstruction of 
the individual images, the entire stack was sequentially rotated in a series of intervals in 
either the x-, y- , z-planes or a combination of axial changes simultaneously, and combined 
into a QuickTime™ movie to allow accurate 3-D spatial representation of 
immunohistochemically labelled cytoskeletal features within the injured axon bundle (360-
degree x-axis rotation in Supplementary Movie 2). This methodology demonstrated a 
complex 3-D environment of axonal and cytoskeletal disorganization within the site of 
injury (selected frames from the Supplementary Movies are shown in Fig. 3.3C). This was 
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highlighted by an obvious swelling of the axon bundle at the point of injury, caused by the 
disorganization of the normally parallel-running and closely packed axons within the 
bundle. In this regard, a number of axons were distorted, and axotomised neurites were 
present (Fig. 3.3B,C). Furthermore, individual axons with several bulb-like NF swellings 
were present within the injury site (Fig. 3.3B). Occasionally, several NF ring-like 
structures, unattached to axons, were also localized within the site of injury (Fig. 3.3B). 
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Figure 3.3 To perform three-dimensional reconstructions through an entire injured axon 
bundle that had been immunolabeled for neurofilament proteins (SMI312), individual 
digital frames were captured in 2µm z-axis intervals through the entire bundle at 48 hrs 
PI (A; cartoons indicate the z-axis depth of the individual image). These images were 
reconstructed using Open-Lab™ software to form an accurate three-dimensional spatial 
representation of immunocytochemically labeled cytoskeletal features within the injured 
axon bundle (B).Within the injured axon bundle, an individual axon with several bulb-
like neurofilament swellings was visualized within the injury site (arrow). Several 
neurofilament ring-like structures, unattached to axons, were also found within the site 
of injury (arrowheads). Using OpenLab™ software, it was possible to rotate the 
compiled image in either the x-, y-, z-axis or axial combinations to fully observe the 
spatial relationships of immunolabeled cytoskeletal structures within the injured axon 
bundle. Several examples of these are presented ( C; cartoons detail the axial rotations 
for each image). Scale bar, 50µm. 
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This thesis has presented a simple, reproducible in vitro model of transient axonal stretch 
injury of cultured primary neurons. This model has a number of methodological 
advantages, including a modifiable and highly reproducible method of injury, and the 
ability to selectively injure and visualize a highly localized region of the axon. To validate 
this model, we have investigated the response of axons and NF proteins to mild axonal 
stretch injury and observed a stereotypy of changes reminiscent of those observed during 
TBI that leads to a high rate of secondary axotomy after 3 days post-injury. 
Previous in vitro studies have performed relatively severe (ranging from 15% to 65% 
stretch of an axon over its initial length) stretch injuries to axons of neuron-like cell lines 
and noted dramatic axonal responses within 24 hrs including axotomy. However, we have 
utilized a methodological approach specifically aimed at performing mild transient axonal 
injury (1-6% stretch) to assess the slow progression of axonal alterations that are 
characteristic of diffuse axonal injury (DAI) evolving over several days. In this regard, 
almost no discernable difference in cytoskeletal arrangement was noted between 
unstretched and stretched axonal bundles by 24 hrs PI. It is important to note that the 
SMI312 cocktail of monoclonal IgGs that we have used labels phosphorylated NFs of all 
subclasses (-H, and -M,). Hence, we were unable to ascertain subtle alterations in the 
phosphorylation state of individual NF subunits or phosphorylation sites following trauma. 
However, by 48 hrs PI, there was a stereotypical response involving a number of 
characteristic cytoskeletal alterations that bear similarities to in viva neuronal responses 
associated with DAI that have been reported previously. For instance, NF immunoreactivity 
was significantly greater in stretched axons compared to surrounding unstretched axons. It 
is possible that this increased NF immunoreactivity reflects their compaction within axons, 
which has been noted previously following DAI (Jafari et al., 1997; Povlishock et al., 1997; 
Okonkwo et al., 1998). It is also possible that this increased SMI312 immunoreactivity 
reflects an alteration in phosphorylation state of some of the NFs present within the injured 
axons. In many cases, at the focal site of the deflection, the well-defined organization of 
NP-positive processes within axon bundles was lost at this time, with individual fibres 
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segregating from each other and becoming undulating and wavy. This is most likely a 
direct, if delayed, response to stretch injury since this "fraying" effect only occurred in 
regions that were directly subjected to stretching. By 72 hrs PI, the majority of injured axon 
bundles appeared to have suffered secondary axotomy, becoming completely severed at the 
site of initial stretch injury. Hence, these results clearly demonstrate a temporal progression 
of axonal changes in response to mild axonal stretch injury, from increased NF 
immunoreactivity to severe axonal pathology and delayed axotomy. 
While the basic analyses discussed above would suggest that all axons undergo a similar 
stereotypical response to mild mechanical insult, this fails to take into account that the 
actual injury levels are most likely different for each axonal bundle injured. Since the same 
fluid pressure (20 psi) was applied for all injuries, it is likely that the injury level for each 
independently injured axonal bundle will be related to the length of the axons. To account 
for this, the actual degree of axonal deflection was calculated for each injured axonal 
bundle, and the same morphological parameters of axonal injury applied above were used 
for analysis. Based upon this analysis it was possible to differentiate between mildly and 
severely injured axons based upon morphological characteristics. For instance, mild strain 
resulted in increased NF immunoreactivity (which may reflect a partial post-traumatic 
alteration in phosphorylation state of some NFs) and the marked development of ring-like 
NF immunoreactive structures within axonal bundles that were rarely axotomised. 
Conversely, at greater strain levels increased NF immunoreactivity was less apparent 
(which may reflect total dephosphorylation of NFs), while axons often became distorted 
and disorganized within axonal bundles and eventually became completely disconnected. 
This suggests that axons do not respond in a stereotypical manner to a mechanical strain 
insult, and indeed that variable degrees of mechanical injury activate different responses 
within axons, with dramatically different outcomes. This is a possible explanation for the 
recent report that impaired axonal transport and altered axolemmal permeability occur in 
distinct populations of damaged axons following TBI (Stone et al., 2004), since it may 
reflect the fact that axons undergoing different degrees of strain in the TBI model respond 
differently. Furthermore, our study supports the notion presented by Stone and colleagues 
(2004) that multiple approaches are required to assess axonal response to injury, and indeed 
49 
the cytoskeletal characteristics that we have used in this study may be useful parameters for 
discriminating between mildly and severely injured axons following TBI. 
Using 3-D imaging technology, the injured axon bundle was reconstructed from a series of 
individual images to provide a clear spatial representation of immunolabelled cytoskeletal 
features following injury. This new and novel methodology provided a significantly 
improved resolution of imaging, and highlighted the substantial disorganisation of axons 
following stretch injury. Intriguingly, NF ring-like structures were often completely 
separate from any nearby axons. It is unclear how these structures develop, or indeed how 
they become disconnected from axons. These abnormal features appear to be associated 
with injury and require further investigation, since they have observed previously in a range 
of conditions resulting in axonal injury including localised axonal transection in vitro 
(Dickson et al., 2000; Chuckowree and Vickers, 2003), physically induced axonal injury in 
vivo (King et al., 1997, 2001) and in the Alzheimer's disease brain (Dickson et al., 1999). 
Furthermore, the reported presence of abnormal bulb-like NF-immunoreactive swellings 
along injured axons has been illustrated previously, and is considered a hallmark of axonal 
injury (Povlishock and Christman, 1995; Maxwell et al., 1997). 
There are several excellent studies that have been reported previously investigating 
different experimental models for stretching axons, which have determined the threshold 
for axotomy, which ranges from 33% in peripheral nerves (Gr11y and Ritchie, 1954), to 15-
24% in a model of inertial injury to guinea pig optic nerves (Meaney et al., 1995), and to 
65% in a cultured human neuron cell-line (Smith et al., 1999). For comparison, the strain 
rate (calculated as 1/initial axon length x 8axon length/ time) applied by Smith et al. (1999) 
was in the range of 26-35 sec-I, while we have applied strain rates of considerably lower 
magnitude, from 0.8 sec-I (100-103% increase in original axon length) to 4.2 sec-I (106%). 
It is rather surprising then, given the high tensile strains reported previously, that in the 
current study even very small levels of mechanical strain (1-3% increase in original axon 
length) cause dramatic changes in axonal structure. A possible explanation for this is that 
the studies in the literature have involved stretching of a relatively long length of the axon 
(greater than 100 µm), in either optic nerve stretch models (Maxwell, 1996; Maxwell and 
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Graham, 1997; Jafari et al., 1997) or in vitro uniaxial stretch of axons (Smith et al., 1999), 
while in this study the injuries were performed upon axons spanning the relatively short 
distance between neuronal clusters (typically less than 100 µm). Another possible 
explanation is that as a consequence of the relatively short length of axonal bundles injured, 
these injuries are performed in close proximity to the axon hillock, which may exacerbate 
axonal responses to trauma. 
In summary, this thesis presents a simple, reproducible model of axonal stretch in jury that 
results in several axonal alterations characteristic of DAl and, in particular, delayed 
axotomy. Furthermore, using this model this thesis has demonstrated that differing degrees 
of injury result in different axonal responses, supporting the idea that axons respond 
heterogeneously to trauma under certain situations. Hence, this model has a number of 
possible applications for further research into understanding neuronal responses to physical 
trauma, and in developing and testing therapeutic agents that specifically target some of the 
aberrant alterations underlying the pathological cascades contributing to DAI. In this 
regard, axolemma permeability alterations are proposed to play an important role in the 
post-injury alteration of the axon cytoskeleton, through the activation of cytoskeletal-
degradative cascades. Thus, it is important to investigate whether the NF alterations 
observed in this chapter are linked to disruptions to axolemma permeability. 
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4 ACUTE CALCIUM INFLUX INITIATES DELAYED CYTOSKELETAL AND 
AXOLEMMA PERMEABILITY ALTERATIONS VIA ACTIVATION OF 
CALCINEURIN. 
4.1 INTRODUCTION 
As illustrated in the previous chapter, axonal stretch injury results in the progressive 
degradation of the axon cytoskeleton, ultimately leading to delayed secondary axotomy 
(Maxwell et al., 1997; Smith et al., 2003). However, the mechanisms underlying this 
evolving form of axonopathy, particularly in regard to cytoskeletal damage, remains 
undefined. One proposed mechanism is that axon shear stress may cause focal axolemmal 
permeability alterations, leading to increased intracellular calcium and the harmful 
activation of calcium-dependant cascades, involving calpain, caspase, and calcineurin, 
which might contribute to cytoskeletal damage (Povlishock, 1993; Povlishock and Pettus, 
1996; Wolf et al., 2001). Indeed, evidence of calcium-induced mitochondrial damage, 
resulting in the release of cytochrome-C, and activation of calcium-modulated spectrin 
degradation following DAI (Buki et al., 1999, 2000) supported the pivotal role of calcium 
dysregulation in the post-injury sequelae. However, cytoskeletal damage in the absence of 
axolemma permeability disruption following in vitro axonal stretch injury suggested that 
another, more subtle, mechanism may underlie the progressive deterioration of the axon 
cytoskeleton (Smith et al., 1999). In this regard, the source of intracellular calcium 
dysregulation following axonal stretch injury remains to be investigated. 
The perturbation of the cytoskeleton in relevant experimental models has been linked to 
impaired axonal transport and, consequently, the formation of axonal swellings (Povlishock 
and Pettus, 1996; Okonkwo et al., 1998; Saatman et al., 1998, 2000, 2003; Postmantur et al, 
2000). The role of specific cytoskeletal changes in axon transport deficits, such as 
compaction, is unclear (Stone et al, 2001). However, there is increasing evidence of 
structural and functional damage to mitochondria following DAI (Lifshitz et al., 2003, 
2004, 2006), which may contribute to the pathophysiology of TBI via either metabolic 
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dysfunction and/or the release of pro-apoptotic factors such as cytochrome-C (Sullivan et 
al., 1999, 2002). In this respect, inhibition of the formation of the mitochondrial 
permeability transition (MPT) pore with cyclosporin-A has been reported to prevent 
cytoskeletal alterations and axonal degeneration following in vivo impact acceleration brain 
injury (Biiki et al, 1999; Okonkwo et al., 1999a&b; Suehiro and Povlishock, 2001). 
However, cyclosporin-A's therapeutic mode of neuroprotection remains to be clearly 
defined as it is also an inhibitor of calcineurin. Importantly, inhibition of calcineurin with 
FK506 has also been shown to attenuate cytoskeletal damage following axonal injury 
(Marmarou and Povlishock, 2006). 
The present study utilizes the in vitro model of transient stretch injury characterised in the 
previous chapter to investigate the temporal relationship between delayed cytoskeletal 
--
damage, axolemma disruption, alterations to intracellular calcium concentration, 
mitochondrial disruption (cytochrome-C release) and secondary axotomy. Furthermore, this 
study will determine whether cyclosporin-A, a MPT pore and calcineurin inhibitor, 
attenuates cytoskeletal damage and secondary axotorny. 
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4.2 MATERIALS AND METHODS 
4.2.1 Cortical cell culture 
Neuron cultures were prepared as outlined in section 2.1 (Materials and Methods). 
Immunolabelling of cortical cultures with antibodies to glial fibrillary acidic protein, GFAP 
(DAKO), Ferritin (ICN Biomedicals Inc.), CDl lb/c (a marker of microglia, White et al. 
1998) and staining with Nuclear Yellow (Molecular Probes) were utilised to detect the 
presence of non-neuronal cells (Table 2.1). 
4.2.2 Experimental axon stretch injury and immunocytochemical analysis 
Axonal stretch injury was conducted according to the procedures presented in chapter 2.2 
(Materials and Methods). As detailed in the previous chapter, stretch injured axon bundles 
were fixed at 24 hrs, 48 hrs, and 72 hrs PI and immunolabelled with antibodies targeting a-
intemexin, NFM, neuronal spectrin, ubiquitin, and cytochrome-C, according to the 
procedures in chapter 2.3 (Materials and Methods). Immunolabelled preparations were 
visualized under an upright fluorescing microscope (Leica DMLB2) with images taken 
using an Optronics Magnafire digital camera as outlined in chapter 2.4 (Materials and 
Methods). Additionally, a series of digital images were captured at l.2µm z-axis intervals 
through the entire thickness of the injured axonal bundle using an Optiscan F900e 
krypton/argon confocal scanning system attached to an Olympus BX50 epifluorescence 
microscope. These images were then constructed into a single stack image using NIH 
ImageJ (version l .37v) software. Thirty-six axon bundles were injured per time point, and 
to ensure reliability, three sets of injuries were conducted at each time point in different 
cultures (total of 324 injured axon bundles). 
4.2.3 Axolemmal permeability 
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Axolemmal permeability following stretch injury was assessed using Alexa 488 hydrazide 
(Molecular Probes), a membrane impermeant fluorescent dye with a molecular weight of 
570 Da. Intracellular accumulation of the dye demonstrates abnormal axolemma 
permeability to small molecules (Smith et al., 1999). Briefly, prior to injury, 200µ1 of 
580µM Alexa 488 hydrazide dissolved in control saline solution (CSS; 120 mM NaCl, 5.4 
mM KCl, 0.8 mM MgC12 , 1.8 mM CaC12 , 15 mM glucose, and 25mM HEPES, pH 7.4) was 
added to culture medium. The axons were stretched in the presence of the dye solution. 
Prior to analysis on a fluorescence microscope (Leica DMLB2), the dye solution was 
washed off using fresh CSS. High (numerical aperture 0.50) and low (numerical aperture 
0.30) m~gnification images were collected using an Optronics Magnafire digital camera to 
determine the percentage of stretch injured axons with dye accumulation at each time point. 
As a positive control, uninjured neuron cultures were permeabilised with a single rinse of 
0.005% Saponin (Sigma) in control saline solution and incubated for 5 minutes with the 
dye solution. As a negative control, the cultures were incubated in the dye solution without 
injury or Saponin, according to the post-injury observation time intervals. The observations 
quantative analysis was not blinded, as the evaluator knew which axons were injured. In 
this regard, the same fluorescent threshold for the control (uninjured) axon bundle was used 
to determine a positive out outcome inn injured axon bundles (on the same coverslip). 
4.2.4 Calcium imaging 
Calcium imaging was utilised to investigate whether there is disruption to intracellular 
calcium following axonal stretch injury. At 1 day prior to imaging, cultured monolayers, 
growing on glass coverslips were transferred to individual 35mm glass petri dishes. The 
Neurobasal™ media, in which the neurons were growing, was gradually replaced with 
artifi~ial cerebrospinal fluid (ACSF, 137 mM NaCl, 5 mM KCl, 5.6 mM glucose, 4-(2-
hydroxyethyl)-l-piperazineethanesulfonic acid, 20 mM HEPES, 0.6 mM KH2P04 , 0.5 mM 
NaiHP04 , 1.4 mM CaC12 , 0.9 mM MgC12 over a time course of 1 hr prior to imaging, to 
promote neuronal survival when imaging. Cells were then loaded with Fluo-4AM calcium 
indicator (lµM, Molecular Probes) for 7 min at 37 °C, washed with fresh ACSF and 
incubated at 37°C for a further 15-20 min prior to imaging. 
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Images (5-25 msec exposure) were captured every 3 sees, 5 rnin before (including at the 
moment of injury) and after axonal stretch injury, using a cooled CCD camera (ORCA, 
Hamamatsu) and fluorescence intensities were analysed using lmageJ (NIH) and custom 
software applications (Matlab, Mathworks). Calcium activity was measured as the average 
pixel intensity (F) in a specified region-of-interest (ROI) of the axon bundle divided by the 
baseline fluorescence intensity in the same ROI at the commencement of the observation 
period (Po). Background fluorescence was subtracted from all frames using the average 
pixel value of an identically shaped ROI close to the axon bundle being observed. Graphs 
representing calcium changes were scaled according to the following formula: (F-Fo)/Fo. 
Spontaneous event frequencies were obtained using a modified Daubechies 4 discrete 
wavelet transformation and analysis algorithm (MatLab, Mathworks). Thapsigargin (lµM) 
was added to positive control cultures and results in the release of calcium from 
intracellular stores (Weber et al., 2001). Axonal stretch injury and calcium imaging was 
also conducted in calcium-free ACSF (ACSF without CaC12 and with lrnM EGTA added). 
4.2.5 Determination of cytochrome-C release from axonal mitochondria following 
injury 
MitoTracker™ green dye (lnvitrogen) was added to cultures at predetermined time-points 
to label axonal mitochondria and determine whether cytochrome-C was localized to 
mitochondria or the cytosol following injury. Prior to injury and at 24 hrs, 48 hrs, 72 hrs PI, 
the medium from the cultures was removed and replaced with fresh pre-warmed 
Neurobasal™ medium containing lOOnM MitoTracker™ green. The cells were incubated in 
this medium for 20 mins, the medium removed, and the cells were washed in pre-warmed 
medium without MitoTracker™ green. The cells were then fixed and irnrnunolabelled for 
cytochrome-C. Cells retained the MitoTracker™ green following fixation and 
permeabilization. 
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4.2.6 Cyclosporin-A and FK506 treatment 
Cyclosporin-A, a known inhibitor of calcineurin and the MPT pore (Biiki et al., 1999), was 
added to cultures prior to injury to investigate the potential role of post-injury 
mitochondrial disruption relative to the release of cytochrome-C and cytoskeletal 
alterations. One hour prior to injury, neuronal cultures were treated with 20nM cyclosporin-
A (Sigma) (Hansson et al., 2004; Mironov et al., 2005). This concentration of cyclosporin-
A is within the range of the lowest dose concentration capable of producing a therapeutic 
effect (Brustovetsky and Dubinsky, 2000; Hansson et al., 2004; Mironov et al., 2005). 
Additionally, as cyclosporin-A was to remain in the culture for a period of 96 hrs, the 
lowest possible concentration was investigated. 
Tacrolimus (FK506, lµM), a potent inhibitor of calcineurin (Bavetta et al., 1999) was 
added to cultures prior to injury to determine whether calcineurin inhibition alone would 
result in an improved survival following axonal stretch injury. One hour prior to injury, 
neuronal cultures were treated with 0.1 µM cyclosporin-A (Sigma) (Lyons et al., 1994). 
FK506 and cyclosporin-A remained in the medium until fixation with 4% 
paraformaldehyde. Following fixation, the treated cells were incubated with antibodies to 
cytoskeletal proteins as described in chapter 2.3 (Materials and Methods). Kaplan-Meier 
survival analyses were conducted using the Graphpad Prism4® software. 
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4.3 RESULTS 
The presence of non-neuronal cells was examined using immunocytochemical techniques. 
Small numbers of non-neuronal cells were present within the culture both prior to after 
stretch injury (Fig. 4.1) as previously reported (Dickson et al., 2000). Substantial glial cell 
proliferation is inhibited by the culture medium (Dickson et al., 2000; Chuckowree and 
Vickers, 2003). These cells were largely associated with the neuronal cell clusters and did 
not come in contact with the axon bundles. Stretch injury resulted in damage to the axon 
bundle independent to any disruption to the non-neuronal cells. 
4.3.1 Delayed cytoskeletal damage and alteration to axolemma permeability. 
Axolemma permeability following injury was examined using a low molecular weight 
tracer, (570Da) Alexa 488 hydrazide dye. With no stretch injury or chemical 
permeabilization, axons did not take up the Alexa 488 hydrazide dye (i.e. the axolemma 
remained impermeant to small molecules). Furthermore, there was no dye uptake at 5 min, 
30 min, and 1 hr Pl. However, chemical permeabilization of unstretched axons with 
Saponin resulted in a substantial uptake of the tracer (Fig. 4.2). In comparison, at 12 hrs PI 
only 9% of stretched axons exhibited any uptake of the fluorescent dye. At 24 hrs PI, 22% 
of stretch-injured axons demonstrated Alexa 488 dye uptake whereas, by 48 hrs PI, 65% of 
stretch-injured axons demonstrated dye uptake (Fig. 4.2). 
The increase in axolemma permeability with increasing PI intervals was associated with 
disruption to the axonal cytoskeleton. Intra-axonal labelling for NFM, a-intemexin and 
neuronal spectrin was relatively ordered and linear at 24 hrs PI (Fig. 4.3). However, 20% of 
stretch-injured axons demonstrated dense and compacted NF immunolabelling at this time 
point. By 48 hrs PI, there was increased disruption of the axonal cytoskeleton, particularly 
in relation to the loss of linear labelling for spectrin, NFM and a-intemexin and the 
development oflocalized axonal swellings, the latter also focally labelled for ubiquitin (Fig. 
4.3). 48 hrs PI was the peak time point for axon bundles (67%), to demonstrate NF 
compaction as also detailed in the previous chapter (chapter 3.3). Cytoskeletal alterations 
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Figure 4.1 Stretch injured axons double immunolabelled for non-neuronal cells. A, C, 
low levels of astrocytes (Red, GF AP) are present in the culture. These non-neuronal 
cells did not associate with .the axonal bundle (Green, NFM) in uninjured cultures (A) 
and were not activated by stretch injury (C). B, Low levels of microglia (Red, Ferritin) 
were present in the culture at 24 hrs PI, but were not associated with the injured axon 
bundle (Green, NFM). D,E, F, Nuclear Yellow staining (D,E) of an axonal swelling 48 
hrs PI, confirms no association of non-neuronal cells with the injured axon bundle (F, 
phase micrograph). Scale bars, 50µm 

Figure 4.2 Axolemma permeability in stretch injured axons. A, Alexa 488 hydrazide dye 
was readily taken up in uninjured axons following chemical permeabilisation of the 
axolemma with saponin. B, A small but detectable amount of dye was taken up into 
stretch injured axons 24 hrs PI (this was compared to Alexa 488 labeling in control 
unstretched axons). C, At 48 hrs PI, dye was readily detected within stretch injured 
axons. Scale bar, 50µm. 
Time post injury (PI) Smin 30 min 1 hr 12 hrs 24 hrs 36 hrs 48 hrs 
% permeability change 0 (0/ 18) 0 (0/ 14) 0 (0/ 12) 9 (3/ 33) 22 (6/ 27) 67 (18/27) 45 (15/ 33) 
Table 4.1 Table shows the percentage of stretch injured axon bundles with permeability 
alterations over a period of 48 hrs PI. 
Figure 4.3 Cytoskeletal alterations following axonal stretch injury to mature cortical 
neurons. No alteration to the cytoskeletal arrangement of spectrin (A), NPM (B) and a-
intemexin (C) was observed at 24 hrs PI. At 48 hrs PI neurofilament compaction (Di) 
and the disruption ofNFM resulting in a 'frayed' morphology (Dii) was observed. This 
abnormal cytoskeletal feature was also present within axons immuno-labeled for a-
intemexin at 48 hrs PI (E). Additionally, there was abnormal, non-linear spectrin 
immunolabelling at 48 hrs PI (F). At 72 hrs PI, there was an increase in axotomy 
resulting in the frank disruption to the entire axon bundle ( G). Associated with these 
cytoskeletal alterations is the accumulation of ubiquitin within a highly localized region 
at 48 hrs PI, corresponding to an axonal swelling (H). Scale bar, 40µm. 

were illustrated using an Optiscan F900e krypton/argon confocal scanning system (Fig. 
4.4). By 48 hrs PI, 18% of stretch-injured axons had progressed to frank secondary 
axotomy, increasing to 50% by 72 hrs PI (Fig 4.3). 
4.3.2 Post-injury calcium alterations 
Acute post axonal stretch injury alterations in free cytosolic calcium ([Ca2+].) was measured 
using the fluorescent calcium dye fluo4-AM. Two peak increases in (F-Fo)/Fo were 
observed following axonal stretch injury. The first peak increase in (F-Fo)/Fo was the 
largest and occurred immediately after stretch injury (Fig 4.SA). This was followed by a 
second delayed peak inc-rease in (F-Fo)/Fo, which was significantly less than the first peak 
increase (Fig 4.5A). All increases in (F-Fo)/Fo were restored back to basal (pre-injury) 
levels over time. 
Calcium was removed from the extracellular ACSF to determine if these post axonal stretch 
injury increases in [Ca2+], were due to influx of calcium from extracellular stores. Stretch 
injury in calcium-free ACSF resulted in an acute peak increase in (F-Fo)/Fo, however, there 
was no significant secondary peak increase in (F-Fo)/Fo as observed in injuries conducted 
in ACSF with calcium (Fig 4.5B). Accordingly, there was no significant difference in the 
first peak increase in (F-Fo)/Fo between injuries conducted in calcium-containing and 
calcium-free ACSF. The thapsigargin-induced release of calcium from intracellular stores, 
conducted in ACSF that contained calcium, resulted in a two peak increase in (F-Fo)/Fo 
similar in profile to that observed following axonal stretch injury in ACSF that contains 
calcium (Fig 4.SC). There was no significant difference in peak increases in (F-Fo)/Fo 
between thapsigargin treated cultures and following axonal stretch injury in calcium-
containing ACSF. 
4.3.3 Mitochondrial disruption and cytochrome-C release. 
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Figure 4.4 1.2 µm optical slices, obtained using laser confocal microscopy, through 
stretch injured axon bundles labeled for NFM at 24-(A), 48-(B) and 72 hrs PI ( C). Scale 
bar. 50µm. 

Figure 4.5 Montage of frames (3 sec/frame) showing calcium alterations within Fluo-
4AM loaded axon bundle, following axonal stretch injury in calcium-containing 
artificial cerebrospinal fluid (ACSF) (* denotes time of injury). Images are in Pseudo-
colour to emphasize alterations in fluorescence of Fluo-4AM. There is an acute post-
injury increase in intracellular calcium levels (illustrated as an increase in fluorescence), 
prior to calcium returning back to basal levels. A,B, C; Bar graphs demonstrate post-
injury calcium alterations following axonal stretch injury. A two-peak increase in 
intracellular levels is observed following axonal stretch-injury (A) and thapsigargin 
treatment (C) in calcium-containing ACSF. B; Only a single peak increase in 
intracellular levels is seen following stretch injury in calcium-free ACSF. Scale bar, 
20µm. 
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Focal accumulation of cytochrome-C occurred at 48 and 72 hrs PI, showing co-localisation 
to axonal segments demonstrating neurofilamentous compaction and axonal swelling (Fig. 
4.6). There was a similar pattern of co-localization of cytochrome-C and MitoTracker™ 
green (a mitochondrial marker) labelling, in uninjured axons as well as stretch-injured 
axons at 24 hrs PI (Fig. 4.6C). Separation of MitoTracker™ Green fluorescence and 
cytochrome-C immunolabelling occurred within stretch injured axons by 48 and 72 hrs Pl. 
This included depletion of cytochrome-C from MitoTracker™ -stained mitochondria, the 
latter also accumulating in focal regions of axonal damage (Fig. 4.6D). 
To determine whether disrupting the release of cytochrome-C through the MPT pore 
attenuates the cytoskeletal damage observed following stretch injury, cyclosporin-A was 
added to cultures prior to injury. At 24 hrs PI, 0 and 20% of stretch-injured axon bundles 
demonstrated NF compaction in cyclosporin A-treated and control preparations, 
respectively. Relatively reduced cytoskeletal and morphological change in cyclosporin A-
treated stretched axons was also evident at 48 hrs PI (Fig. 4.7). At this time point, 20% of 
control preparations demonstrated secondary axotomy, whereas no cyclosporin A-treated 
cultures had progressed to frank degeneration. At 72 hrs PI, 50% of control preparations 
and 7% of cyclosporin A-treated bundles had progressed to secondary axotomy. Kaplan-
Meier survival analyses demonstrated that there was a significant decrease in axotomy 
(p<0.05) in cyclosporin-A treated cultures in comparison to untreated cultures. In 
cyclosporin-A treated cultures, there was a reduction in the number of injured axons 
demonstrating axon swellings in comparison to untreated cultures. At 72 hrs PI, 57% of 
untreated cultures and 12% of treated injured axon bundles displayed swellings 
respectively. Furthermore, there was a reduction in the number of injured axon bundles 
demonstrating release and accumulation of cytochrome-C in treated cultures in comparison 
to untreated cultures. 
4.3.4 FK506 treatment of stretch injured cultures 
FK 506, a potent inhibitor of calcineurin (Bavetta et al., 1999), was administered to cultures 
prior to axonal stretch injury to determine whether the attenuation of secondary axotomy 
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Figure 4.6 Mitochondrial dysfunction and accumulation of cytochrome-C within an 
axon swelling. A, -B, Double immunofluorescence labelling for NFM (green) and 
cytochrome-C (red) of a stretch injured axon at 48 hrs and 72 hrs PI, respectively. The 
accumulation of cytochrome-C was highly localized to regions of maximal cytoskeletal 
damage. C, D, Mitochondria fluorescently labeled with MitoTracker™ green show co-
localization with cytochrome-C (red) in a stretch injured axon at 24 hrs PI (C).At 48 hrs 
PI, there was accumulation of cytochrome-C within the centre of the axon swelling and 
loss of co-localization with MitoTracker™ green on the periphery of the axon swelling 
(D). Inset images demonstrate cytochrome-C immunolabelling (i) to sub-regions of the 
axonal swelling that are not co-localized to mitochondrial elements labeled with 
MitoTracker™ green (ii). Scale bars, 40µm. 

Figure 4. 7 The therapeutic effect of cyclosporin-A treatment on stretch injured axons. A, 
There is no alteration to the cytoskeletal organization of NFM (green) and to the 
immunoreactive profile of cytochrome-C (red) at 24 hrs PI in cyclosporin-A treated 
cultures. B, In untreated cultures at 48 hrs PI, NFM-labeled axons are disrupted and 
there is an accumulation of cytochrome-C highly localized within axon swellings. C, 
However, in cyclosporin-A treated cultures, accumulation of cytochrome-C spatially 
associated with minor cytoskeletal damage was present maximally at 96 hrs Pl. The bar 
graphs compare the percentage of injured axon bundles with cytoskeletal alterations 
between cyclosporin-A treated and untreated cultures from 24 hrs to 96 hrs Pl. Only 
cyclosporin-A treated cultures examined at 96 hrs PI as most untreated bundles had 
progressed to secondary axotomy. The line graph is a Kaplan-Meier survival curve, 
illustrating a reduction in axotomy between cyclosporin-A treated and untreated 
cultures. Scale bar, 50µm. 
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following cyclosporin-A treatment was due to inhibition of the MPT pore or calcineurin. At 
24 hrs PI, no stretch injured axon bundles treated with FK506 had progressed to secondary 
axotomy. 3% of treated stretch injured axon bundles progressed to secondary axotomy, 
significantly less than untreated control injured bundles (Fig. 4.8). At 72 hrs PI only 5% of 
FK506 treated cultures had progressed to secondary axotomy which was significantly less 
that in untreated control cultures (50%) (Fig. 4.8). 
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Figure 4.8 Stretch injured axon bundles, pre-treated with the calcineurin inhibitor 
FK506. A,B,C; There is no alteration to the cytoskeletal organization of NFM (green) 
and to the immunoreactive profile of cytochrome-C (red) at 24 hrs PI (A) and 48 hrs PI 
(B). Only 5% of FK506 treated injured axon bundles had progressed to secondary 
axotomy ( C). The bar graphs compare the percentage of injured axon bundles 
progressing to secondary axotomy between FK506 treated and untreated cultures from 
24 hrs to 72 hrs Pl. Significantly (P<0.05) more untreated stretch injured axon bundles 
progressed to secondary axotomy at 48 hrs and 72 hrs PI compared to FK506. Scale bar, 
25µm. 
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This study has further investigated the series of stereotypical cellular changes leading to 
delayed axotomy. Cellular changes included compaction of NFs, derangement of other 
cytoskeletal proteins, cytoplasmic accumulation of cytochrome-C and axon swelling. 
Axolemmal permeability alterations were also demonstrated, but developed subsequent to 
the injury. Acute alterations to intracellular calcium were also illustrated immediately 
following stretch injury. Mitochondrial disruption and inhibition of calcineurin may be a 
key pathological alteration leading to progressive axonal degeneration, as blocking of the 
MPT pore and/or calcineurin with cyclosporin-A and FK506 attenuated many of these 
cellular changes, as well as secondary axotomy. 
Cytoskeletal changes in stretch-injured neurons in the current in vitro model included NF 
compaction, the loss of linear organization of filamentous proteins and accumulation in 
axonal swellings. NF compaction within axons has been described in in viva models of 
brain injury (Gallyas et al., 2002; Marmarou et al., 2005). It is unclear whether the current 
data indicate that NF compaction following axonal stretch injury necessarily predates 
secondary axotomy. However, it may not be that all axons showing such post-injury 
cytoskeletal alterations will inevitably progress to secondary degeneration (Stone et al., 
2001). Indeed, secondary degeneration is more complex than previously thought, and is 
possibly initiated via multiple pathways, as highlighted by gene expression analyses 
(Morrison et al., 2000). 
Shear strain injury to axons has been proposed to lead to transient, focal disruption of the 
axonal membrane, concomitant with an overall increase in intra-axonal calcium (Tomei et 
al., 1990; Povlishock, 1993; Maxwell et al., 1995; Povlishock and Pettus, 1996; Wolf et al., 
2001; Stone et al., 2004). Following axonal stretch injury to NT2 cells, Smith et al (1999) 
reported initial lack of membrane permeability to dyes. In further work with the same 
model (Wolf et al., 2001), it was demonstrated that stretch-induced strain on the axonal 
membrane lead to acute and abnormal Na+ influx through mechanosensitive channels, 
triggering a reverse of the Na+/Ca2+ exchanger, activation of voltage-gated Ca2+ channels 
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and subsequent pathological influx of Ca2+. Geddes-Klein et al. (2006) demonstrated that 
biaxial rather than axial stretch of the axons of cultured cortical neurons was more effective 
at causing acute axolemmal permeability and Ca2+ influx. The current study involved 
transient axonal stretch in cultures maintained for longer periods of time and we have 
shown in this model that there were no axolemmal permeability alterations immediately, 
and up to 12 hrs, following injury. Rather, axolemma permeability alterations were delayed 
and closely associated with the disruption of the axon cytoskeleton following stretch injury. 
These results indicate that the relatively mild stretch injury utilized in this thesis is not 
sufficient to cause immediate perturbation of the axolemmal membrane. Interestingly, the 
current study shows two significant increases in [Ca2+]1 following axonal stretch injury, the 
first and largest increase occurring immediately after injury followed by a smaller delayed 
increase. The first and more remarkable increase in [Ca2+Ji appears to be due to release of 
caldum from intracellular stores' as removal of calcium from extracellular stores does not 
prevent this increase. Conversely, the second [Ca2+]1 increase is significantly lower when 
extracellular calcium is removed. The release of calcium from intracellular stores following 
injury has been illustrated in other in vitro models of axonal injury (Weber et al., 2001; 
Lusardi et al., 2004) and may also result in calcium mediated calcium entry via membrane 
receptors such as N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors and L- and 
N-type calcium channels (Weber et al., 2001; Mobley et al., 2003). This may provide an 
explanation for the secondary increase in [Ca2+] 1, which is from extracellular stores, as the 
thapsigargin-induced release of calcium from only intracellular stores also results in a 
secondary increase in calcium. Other axonal stretch injury studies have demonstrated 
structural changes and calcium influx modulated by TTX-sensitive voltage-gated channels 
(Iwata et al., 2004). In this regard, increased [Ca2+]1leads to proteolytic cleavage of voltage-
gated sodium channels which may in tum promote persistent elevations of [Ca2+]1• 
Although persistent increased [Ca2+]1 levels were not demonstrated in this study, the 
significant increase in [Ca2+]1 might contribute to the secondary degeneration of the injured 
axon via the release of cytochrome-C and the activation of calcineurin and caspases. 
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In this thesis, mild axonal stretch injury also resulted in the delayed accumulation of 
cytochrome-C within highly localized regions of the injured axon, in association with 
regions of cytoskeletal disruption. Cytochrome-C release within traumatically injured 
axons has been proposed to have a role in stimulating apoptosis and neuronal degeneration 
(Btiki et al., 2000). The delayed release and accumulation of cytochrome-Chas also been 
reported in ischemic and TBI models (Fujimura et al., 1998; Pike et al., 1998), as well as 
following excitotoxic injury (Luetjens et al., 2000). This study demonstrates that 
cytochrome-C accumulation in the axon represents abnormal release into the cytosol rather 
than simply indicating the accumulation of mitochondria containing this protein. Release of 
cytochrome-C from mitochondria may have several detrimental effects, for example, 
disruption of normal mitochondrial respiration and/or activation of the caspase cascade 
resulting in apoptosis (Liu et al., 1996; Li et al., 1997). With respect to traumatic brain 
injury, Bilki et al. (2000) have suggested that localized release of cytochrome-C in 
damaged axons results in the activation of caspases (eg caspase 3) that may act directly on 
cytoskeletal elements such as spectrin. However, calpain activity has also been reported to 
contribute to progressive intra-axonal cytoskeletal damage and secondary axotomy in an 
experimental optic nerve stretch injury model (Saatman et al., 2003). As previously stated, 
cytoskeletal damage and secondary apoptosis may be initiated via multiple pathways, 
however, it is clear that mitochondrial damage is likely to play an important role (Morrison 
et al., 2000). Mitochondrial damage may result in disruption to mitochondrial respiration 
(Vink et al., 1990), release of reactive oxidative species (Lifshitz et al, 2003, 2004) and 
disruption to calcium homeostasis (Xiong et al., 1997). Cyclosporin-A has been found to 
attenuate mitochondrial dysfunction in a cortical impact model of TBI (Sullivan et al., 
1999). Additionally, cyclosporin-A pre-treatment before impact-acceleration brain injury of 
rats reduced subsequent immunohistochemically identifiable axonal damage (Okonkwo et 
al., 1999). Likewise, the current study shows that a single pre-treatment of neuronal 
cultures with cyclosporin-A reduced the progression of axonal injury into neurite swellings 
and secondary axotomy. This investigation with neurons isolated in culture demonstrates 
that the neuroprotective effect is likely to be axon-specific, potentially reducing damage to 
mitochondrial membrane integrity and the release of cytochrome-C into the cytosol. 
Interestingly, cyclosporin-A did not have an effect on the development of specific 
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cytoskeletal changes such as NF compaction. Although previous in viva experiments report 
attenuation of cytoskeletal damage following constant injections with cyclosporin-A (Riess 
et al., 2001), it is difficult to translate the therapeutic time window and dosage into in vitro 
models, particularly as constant addition of cyclosporin-A or changes in media may have a 
further toxic effect on the neurons. Hence, a single pre-treatment of cyclosporin-A was 
given to attenuate acute, and possibly chronic, axonal disruption. 
Another immunophilin ligand, FK506, was found to attenuate secondary axotomy, 
similarly to cyclosporin-A. In other studies FK506 was reported to reduce axonal swelling 
but not neurofilamentous compaction following impact-acceleration injury in rats 
(Marmarou and Povlishock, 2006). These data indicate that NF compaction, which likely 
follows cleavage of filament side-arms, occurs through the activation of intracellular 
processes unrelated to the site of action of the immunophilin ligands, and also strongly 
supports the proposal that NF compaction may not be a critical pathological change leading 
to axonal swelling, axon transport deficits and degeneration (eg Stone et al., 2001; 
Marmarou et al., 2005). FK506 itself does not appear to inhibit the MPT pore (Friberg et 
al., 1998), indicating the intriguing possibility that both FK506 and cyclosporin-A may be 
acting through inhibition of calcineurin activity to attenuate axonal pathology following 
injury. Indeed, calcineurin inhibition with either cyclosporin-A or FK506 attenuates axonal 
degeneration following calcium-induced hypoxic damage to white matter in rats as addition 
of rapamycin, which binds to the same immunophilin as FK506, reverses this 
neuroprotective effect (Mobley et al., 2003). Calcineurin inhibition is also shown to protect 
mitochondria from losing their membranous structure following injury, therefore 
preventing the detrimental release of intracellular calcium into the cytosol (Mobley et al., 
2003). As this study has already shown the significant release of calcium form intracellular 
stores following stretch injury, this may provide a possible mechanism of protection. An 
interesting extension to this study would be to determine the effect of FK506 treatment on 
the calcium transients observed following stretch injury. This extension would provide 
valuable insight into whether the acute calcium transients triggered at the moment of injury 
are linked to the delayed progression to secondary axotomy. Furthermore, the therapeutic 
potential of FK506 after injury (rather than pre-exposure) can be determined. 
65 
In summary, although limitations of a cell culture model are an important caveat for direct 
translation to human TBI, the interpretation of these results in conjunction with previous in 
vivo and in vitro studies, provides evidence that calcineurin inhibition and the targeting of 
specific post-injury cellular changes that develop within axons may be a useful approach 
for reducing DAI and secondary axotomy following brain trauma. This chapter 
demonstrates the post-injury activation of cytoskeletal degradative pathways, however, it 
does not investigate the activation of other pro-apoptotic pathways, such as the UPS, which 
have also been demonstrated to be initiated following TBI (Schweitzer et al., 1993). 
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5 INHIBITION OF THE UBIQUITIN PROTEASOME SYSTEM FOLLOWING 
AXONAL INJURY ACCELERATES PROGRESSION TO SECONDARY 
AXOTOMY. 
5.1 INTRODUCTION 
The accumulation of ubiquitin conjugates and inclusion bodies containing ubiquitin is 
associated with the lesions of several chronic neurodegenerative diseases including the 
neurofibrillary tangles of Alzheimer' s disease and the Lewy bodies in Parkinson' s disease 
(Alves-Rodrigues, 1998; Glickman and Ciechanover, 2002. Indeed, a recent study of 
human TBI cases has reported the rapid axonal accumulation of proteins implicated in 
neurodegenerative diseases, including Alzheimer's disease and synucleinopathies (Uryu et 
al., 2007). In regard to TBI, although previous studies have provided significant evidence 
linking cytoskeletal alterations to disrupted axonal transport (Maxwell et al, 1997; Graham 
et al., 2000; Povlishock and Katz, 2005), the specific sequence of events leading to 
transport interruption, protein accumulation and degeneration have not been fully 
established. 
The molecular mechanisms underlying delayed axonal degeneration are not fully 
understood, but a crucial role has been ascribed to the activity of the UPS (Korhonen and 
Lindholm, 2004). Altered UPS function, characterized by ubiquitin inclusions, has been 
reported in in vivo models of TBI (Schweitzer et al., 1993; Li and Farooque, 1996) and 
neurodegenerative diseases (e.g. Ciechanover and Brundin, 2003; Mackenzie and Feldman, 
2005; Forman et al., 2006; Josephs et al., 2007). In both animal models and human TBI 
cases, ubiquitin-immunolabelled inclusions have been identified in axon swellings 
(Schweitzer et al., 1993; Ahlgren et al., 1996). As ubiquitin inclusions were found in both 
axon swellings and the terminal bulb of severed axons following injury, it has been 
proposed that ubiquitin accumulation contributes to the eventual axotomy and neuronal 
degeneration (Schweitzer et al., 1993). Accordingly, animal models using transection of 
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cultured neurons or crush lesions of the optic nerve in vivo reported UPS involvement only 
at the early stages of Wallerian degeneration, and this could be delayed following 
pharmacological inhibition of the UPS (Zhai et al., 2003). These results provide important 
information on the role of the UPS in the rapid degeneration of axons within a few hours of 
injury and in Wallerian degeneration following primary axotomy. However, there is little 
known about the role of the UPS in the delayed (secondary) axotomy of axons exposed to 
mild to moderate mechanical trauma, such as the transient stretch/shear injury that leads to 
diffuse axonal injury following closed brain trauma. 
In this study, the role of the UPS in the in vitro model of axonal stretch injury was 
examined, including both immunocytochemical analysis of ubiquitin accumulation and 
pharmacological inhibition of the UPS. 
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5.2 MATERIALS AND METHODS 
5.2.1 Cortical neuron culture and ubiquitin proteasome inhibition 
Cortical neuron cultures were prepared as outlined in chapter 2.1 (Materials and Methods). 
Cortical cell cultures were pre-treated with either 5 µM MG132 (Zhai et al., 2003), 0.5µM 
Lactacystin, or vehicle control 30 mins prior to injury. Previous studies suggested pre-
treatment of neuronal cultures with MG 132, a peptide-based reversible proteasome 
inhibitor, in neuronal cultures delayed degeneration with UPS involvement only at the early 
stages of degeneration (Zhai et al., 2003). Lactacystin, a selective inhibitor of the 20 S 
proteasome, has also been found to be neuroprotective in injured neuronal cultures (Yew et 
al., 2005; Meller et al., 2008). Additionally, the MG132 and Lactacystin concentration used 
in this study was shown not to be detrimental to neuronal health in culture over an extended 
period of time (Dent and Kalil, 2001; Macinnis and Campenot, 2005). 
5.2.2 Experimental stretch injury and immunocytochemistry 
Axonal stretch injury was conducted according to the procedures presented in chapter 2.2 
(Materials and Methods). As detailed in the previous chapter, stretch injured axon bundles 
were fixed at 24 hrs, 48 hrs, and 72 hrs PI and immunolabelled with antibodies targeting 
ubiquitin, and phosphorylated neurofilament (SM1312). The cells were then washed and 
incubated with the species appropriate goat anti-mouse Alexa Fluor 488 or goat anti-rabbit 
Alexa Fluor 594 secondary antibody (Molecular Probes, Eugene, OR), according to the 
procedures in chapter 2.3 (Materials and Methods). Immunolabelled preparations were 
visualized under an upright fluorescing microscope (Leica DMLB2) with images taken 
using an Optronics Magnafire digital camera as outlined in chapter 2.4 (Materials and 
Methods). Secondary axotomy was defined as complete breakage of the axonal bundle, and 
these were counted and presented as a percentage of the total number of injured axon 
bundles. Three axonal bundles were stretch-injured per coverslip with two uninjured axon 
bundles on the same coverslip used as controls. For quantative analysis, all injured axonal 
bundles were assessed under 40X magnification .. F01ty-two axon bundles were injured per 
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time-point, and to ensure reliability, three sets of injuries were conducted at each time-point 
in different cultures. Percentages were calculated as the total number of injured axon 
bundles per time-point across the three sets of different culture, and means are reported ± 
standard error of the mean (SEM). Two way ANOV A statistical analyses were performed 




To examine the role of the UPS in mild to moderate axonal injury, stretch injured axons 
were immunolabelled with antibodies against ubiquitin at 24, 48 and 72 hrs PI in addition 
to neurofilament to confirm the cytoskeletal changes described in the previous chapters. At 
24 hrs PI, ubiquitin immunolabelling within the injured axon remained diffuse and evenly 
distributed, with no significant foci of accumulation. At 48 hrs PI, an accumulation of 
ubiquitin occurred and was localized to swollen regions of the axon bundle. Neurofilament 
alterations within these axonal swellings included ring-like structures, 'tangles' and loss of 
ordered arrangement as described in the previous chapter. Axonal injury resulted in injured 
axons progressing to secondary axotomy at 72 hrs PI as also demonstrated previously (Fig. 
3.lB). Ubiquitin immunoreactivity at this time point was increased and concentrated at the 
terminal region of injured axons following secondary axotomy (Fig. 5.lC). 
5.3.l MG132 and Lactacystin administration 
To determine whether pharmacological inhibition of the UPS could perturb delayed 
axotomy due to stretch injury, neuronal cultures were pre-treated with MG 132 and 
lactacystin. Initial experiments indicated no significant alterations in cell survival and 
morphology over 72 hrs in uninjured cultures following addition of the proteasomal 
inhibitors (Fig. 5.2A,B). Ubiquitin immunoreactivity was minimal in MG132- and 
lactacystin-treated cultures. There was no statistically significant increase (p=<0.05) in 
axotomy between MG132/lactacystin-treated and untreated injured cultures at 24 hrs PI 
(Fig. 5.3). However, at 48 hrs PI, there was a significant increase (p=<0.05) in the number 
of axon bundles progressing to axotomy following MG132 (59.3%+/- 12%) and lactacystin 
(43.6% +/- 4.5%) treatment as compared to 26.4% (+/- 8%) of untreated cultures (Fig. 
5 .3B). Additionally, there was decreased ubiquitin immunoreactivity within injured axon 
swellings at 48 hrs PI as compared to untreated culture preparations. In treated cultures 
axonal swellings were primarily associated with increased cytoskeletal damage (Fig. 5.2D). 
By 72 hrs PI, axonal stretch injury had induced axotomy in 94.7% ( +/- 4%) of MG 132 and 
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Figure 5.1 Alterations to neurofilament and ubiquitin immunolabelling following axonal 
stretch injury. A, Phosphorylated neurofilament (SMI312) and ubiquitin alterations were 
minimal in untreated cultures at 24 hrs Pl. B, At 48 hrs PI, neurofilaments became 
disrupted, displaying a highly dystrophic morphology within axon swellings of untreated 
cultures. Ubiquitin accumulation within axon swellings was evident in untreated cultures 
at 48 hrs PI, localized to regions of neurofilament damage and neurofilament ring-like 
structures (arrows). C, At 72 hrs PI, untreated stretch injured axons had progressed to 
secondary axotomy with increased neurofilament ring-like structures around the stretch-
injured axon bundles. Ubiquitin accumulation was localized within the terminal bulb of 
the severed axon (arrows). D, Graph showing the percentage of untreated injured axon 
bundles displaying cytoskeletal damage over 72 hrs Pl. Error bars are representative of 
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Figure 5.2 Protease inhibition in mature neurons. Uninjured neuronal cultures treated 
with 5µM MG132 (A) and 0.5µM lactacystin (B) did not exhibit any major alterations to 
cytoskeletal organization up to 72 hrs Pl. Increased neurofilament damage and axotomy 
was evident within lactacystin (C) and MG132 (D) treated injured axons (arrows 
indicate sites of axotomy). Scale bars, 50µm. 
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Figure 5.3 Graph showing the percentage of MG 132, lactacystin treated and untreated 
injured axon bundles progressing to secondary axotomy over 72 hrs Pl. Error bars are 
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79% (+/- 5.3%) of Lactacystin treated cultures, which was significantly (p<0.05) higher 
than in untreated cultures (Fig. 5.3). 
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5.4 DISCUSSION 
Reactive axonal alterations resulting in the rapid accumulation of proteins within axon 
swellings play a pivotal role in the evolution of axonal changes, such as DAI, following 
TBI (Buki and Povlishock, 2006). In the present study, we have demonstrated that mild to 
moderate axonal stretch injury induced the delayed accumulation of ubiquitin within 
focally swollen axon bundles. This delayed accumulation of ubiquitin within swellings, 
evident from only 48 hrs PI onwards, was also highly localized to regions of maximal 
cytoskeletal damage. Ubiquitin accumulation within axon swellings is a common feature of 
human brain and spinal cord trauma (e.g. Martin et al., 1990; Gultekin and Smith, 1994; 
Sherriff et al, 1994). Early animal TBI models reported the rapid accumulation of ubiquitin 
within axon swellings immediately prior to secondary axotomy (Schweitzer et al., 1993). 
However, these animal models involved more severe injuries that resulted in rapid 
- - -
secondary axotomy, unlike the model used in this study where secondary axotomy is 
maximal at 7~ hours Pl. Further studies of human and animal spinal cord trauma also 
reported accumulation of ubiquitin within axon swellings (Li and Farooque, 1996; Ahlgren 
et al., 1996). Initially, this ubiquitin accumulation was proposed to be involved in the 
degradation of proteins accumulating in axonal swellings (Li and Farooque, 1996). Over 
recent years, the accumulation of ubiquitin within axonal swellings was considered to be 
indicative of UPS dysfunction, reflected in an inability to remove ubiquitinated proteins 
from axon swellings subsequently contributing to the neuronal degeneration (Ehlers, 2004; 
Korhonen and Lindholm, 2004). Evidence of axonal swellings containing ubiquitinated 
material in neurodegenerative diseases supports this hypothesis (Guo et al., 2000; Lye and 
Shores, 2000; Plassman et al., 2000). However, it is not clear whether the PI accumulation 
of ubiquitin within swellings directly contributes to susceptibility to secondary axotomy. 
To determine the involvement of ubiquitin in relation to secondary axotomy, we 
pharmacologically inhibited the UPS using MG132 and Lactacystin. This resulted in a 
significant increase in the number of injured axon bundles progressing to secondary 
axotomy when compared to untreated cultures. Coupled with the focal accumulation of 
ubiquitin immunoreactivity by 48 hrs PI, this data indicates that the UPS has a potentially 
protective role with respect to damaged axon bundles progressing to secondary axotomy. 
73 
Proteasome inhibition by Lactacystin in uninjured primary neuronal cells was found to 
induce both potentially neuroprotective and pro-apoptotic transcriptional responses (Yew et 
al., 2005). In the current study, the application of both proteasomal inhibitors did not result 
in alterations to morphology or apoptosis in uninjured cultures over 72 hrs Pl. Interestingly; 
using transection models of the rat optic nerve and of cultured rat neurons, MG 132 was 
found to delay the onset of Wallerian degeneration, suggesting local degeneration of the 
severed distal axon segment via the UPS (Zhai et al., 2003; Macinnis and Campenot, 
2005). In contrast, the current model of transient axonal stretch injury is associated with 
gradual cellular changes and cytoskeletal re-arrangements within intact axon bundles (refer 
to chapter 3) that interact to determine the susceptibility of the axonal bundle for secondary 
axotomy. The dynamic role of the UPS in protecting axon bundles from secondary 
axotomy within the current model is not fully known and it is possible that ubiquitin 
accumulation in stretch-injured axon bundles may be caused by increased local ubiquitin 
activity, reduced ubiquitin C-terminal hydrolase activity (Bizzi et al., 1991), accumulation 
in lysosomes and/or disruption of axonal transport (Li and Farooque, 1996). It is likely that 
the UPS changes in axon bundles post-injury are critically associated with alterations to, 
and degradation of, the cytoskeleton in axon swellings (chapter 4; Uryu et al., 2007). In this 
regard, inhibition of UPS activity in injured axon bundles accelerated secondary axotomy 
and also increased cytoskeletal abnormalities within axon swelling. This suggests the 
possible neuroprotective role of the UPS in degrading abnormal cytoskeletal elements and 
accumulated proteins results in delayed secondary axotomy. It is important to note that 
other cell death mechanisms are also activated following mild to moderate axonal injury, 
which may ultimately initiate secondary axotomy (Iwata et al., 2004; Pfister et al., 2004; 
Serbest et al., 2007). 
In summary, UPS activity may have a neuroprotective function by inhibiting cytoskeletal 
disruption and degeneration, thus decreasing the likelihood of damaged axon bundles 
progressing to secondary axotomy. 
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6 ACUTE AXONAL STRETCH INJURY INDUCES NEURITE SPROUTING. 
6.1 INTRODUCTION 
Experimental severance of axons has been shown to induce regenerative sprouting in spinal 
and cortical neurons (Carmichael, 2003), which has been suggested as a possible substrate 
for abnormal synaptic connections implicated in post-traumatic epilepsy (McKinney et al., 
1997). Furthermore, collateral sprouting of 'upstream' segments of long axons that are 
damaged in lower segments of the spinal cord has been proposed to contribute to some 
degree of functional recovery (Hagg, 2006). However, mild to moderate non-penetrative 
forms of brain trauma do not result in substantial primary axotomy at the time of injury. 
Instead, a cascade of intra-axonal biochemical and structural changes leads to axonal 
swelling and secondary axotomy over the days and weeks following injury (Stone et_ al., 
2001). This evolving axonal pathology, also known as DAI, relates to a sequelae of fqpal 
cellular alterations set in train from the initial transient stretch and shear forces at the 
instant of injury. In vivo studies in related experimental models have indicated that axonal 
swellings associated with DAI may also give rise to axonal sprouts, although the cellular 
dynamics underlying this response are unknown, as well as the potential contribution to the 
development of post-traumatic epileptiform activity. 
During development, calcium signalling pathways and cytoskeletal dynamics are an 
important regulator of initial axon growth and guidance (Henley and Poo, 2004; Wen et al., 
2004) as well as the formation of collateral branches (Gallo and Letourneau, 1998; 
Hutchins and Kalil, 2008). This thesis will sick to investigate whether post-injury sequelae 
is associated with axonal sprouting, and to determine if such sprouting relies on actin 
dynamics and calcium-mediated enzyme activation. 
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6.2 MATERIALSANDMETHODS 
6.2.1 Cortical cell culture and experimental axonal stretch injury 
Cortical neuron cultures were prepared as outlined in chapter 2.1 (Materials and Methods) 
and in vitro stretch injuries were pe1f01med as described in chapter 2.2 (Materials and 
Methods. 0.5µM tacrolimus (FK506), a known inhibitor of calcineurin, and latrunculin-A, 
an inhibitor of actin polymerisation, were added to injured and sham cultures one prior to 
axonal stretch injury. At 24 hrs, 48 hrs, and 72 hrs PI stretch injured cells were fixed and 
immunolabelled with antibodies targeting growth-associated protein-43 (GAP43) or NFM 
according to chapter 2.3 (Materials and Methods). Actin filaments (F-actin) were stained 
with 4µ1/ml phalloidin conjugated to AlexaFluor 488 (Molecular Probes, Eugene, OR). 
Immunolabelled preparations were visualized under an upright fluorescing microscope 
(Leica DMLB2) with images taken using an Optronics Magnafire digital camera as outlined 
in chapter 2 .4 (Materials and Methods). 
6.2.2 Live cell imaging 
At 48 hrs PI, lµI of Cell Tracker CM-Dil (DiI) (Molecular Probes, Oregon) was added to 
culture and incubated for 15 min. The injured cells were rinsed three times and placed in 
"imaging buffer" (in mM: NaCl, 5 KCl, 0.2 CaC12 , 1 MgC12, 30 dextrose, and 25 HEPES, 
pH 7 .3) (Zhang and Benson, 2001) for imaging. A time series of images were captured 
from a fluorescence (Leica DM IRB) inverted microscope (40X/0.80), equipped with a 
heated stage. Digital images were captured with a Hamamatsu ORCA-ER digital camera 
using OpenLab ™ software. 
6.2.3 Scanning electron microscopy 
Stretch injured and sham cultures were prepared for scanning electron microscopy as 
previously described (Chuckowree and Vickers, 2003). Briefly, cells were fixed in 2.5% 
glutaraldehyde/0.1 % phosphate buffer (pH 7.4) and post-fixed with 0.1 % osmium 
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tetroxide. Specimens were dehydrated by progression through an ethanol series, critical 
point dried and sputter coated with gold before examination under a Jeol-840 scanning 
electron microscope. Digital images were captured using ImageSlave software. 
6.2.4 Real-time polymerase chain reaction analysis 
Real time quantitative RT-PCR reactions were carried out using the Quantitect® SYBR® 
Green RT-PCR kit (Qiagen; Applied Biosystems Inc. Foster City, CA) in a 10 µl volume 
on a Rotor-gene 2000 (Corbett Research, Mortlake, NSW, Australia). A standard curve was 
prepared using PCR products derived from cDNA for the primer set to ensure that the 
reaction was efficient over the range of the RNA samples. A standard curve was also 
prepared for the primer set using serial dilutions of brain RNA to ensure that the amount of 
RNA added to each RT-PCR reaction was not inhibiting the efficiency of the RT-PCR 
reaction. GAPDH was used as the housekeeping gene. The CT values of all samples were 
normalized to GAPDH by dividing the CT value of the gene of interest by the CT value of 
GAPDH for each sample. The GAPDH normalized CT values were then divided by the 




6.3.1 Delayed cytoskeletal alterations follow axonal stretch injury. 
As previously described (chapter 3) the axonal stretch injury model did not result in 
primary axotomy but induced a progressive series of cytoskeletal alterations, maximal at 48 
hrs post-injury (PI), ultimately leading to delayed axotomy of the majority (65%) of 
stretch-injured axonal bundles by 72 hrs PI. Additionally, injured axon bundle shafts 
displayed a 'frayed' morphology with neurofilament immunolabelling, which was maximal 
at 48 hrs PI (30% of injured axon bundles). Many of the surviving axon bundles at 72 hours 
PI also demonstrated this disordered appearance (Fig. 6.lC). The protruding processes from 
the 'frayed' region of the axon bundle did not have the same morphology as the 
'undulating' axons that had already progressed to secondary axotomy seen at 72 hrs PI 
(Fig. 6.lD). It was difficult to assess the length of these protrusions 
immunocytochemically, due to their short length ( 50µm>). 
6.3.2 Live imaging of injured axon bundle 
Swollen and frayed regions of the injured axon bundle were examined with live imaging at 
48 hrs PI for 15 minutes (Fig. 6.2) using the lipophilic dye, Dil. Highly motile filopodia-
like sprout protrusions were identified in these regions of axonal swelling (Fig. 6.3; 
supplementary movie 3). These protrusions were identifiable using NIH Image J (Fig. 6.3) 
and the movements of the protrusions were in independent directions illustrating non-
Brownian movement. 
6.3.3 Scanning electron microscopy and immunohistochemistry 
Scanning electron microscopy at 24, 48 and 72 hrs PI was utilised to determine the 
morphological features of injury-related sprouting (Fig. 6.3A-C). At 24 hrs PI, the axon 
bundle shaft was smooth and ordered with no significant protrusions. At 48 hrs PI, fine 
protrusions that resembled extended filopodia were observed from the axonal bundle shaft 
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Figure 6.1 Mild to moderate axonal stretch injury induced a delayed series of neuritic 
alterations -ultimately resulting m secondary axotomy. A, Utilising NFM 
immunolabelling, at 24 hrs PI, there was no significant cytoskeletal disruption to stretch-
injured mature axon bundles, however, at 48 hrs PI, a significant percentage (P<0.05) 
(D) of stretch injured axons displayed a 'frayed' morphology (B, arrow). C, At 72 hrs PI, 
a significant (P<0.05) number of stretch-injured axon bundles had progressed to 
secondary axotomy (arrows). E, The processes in the frayed region of the axon bundle 
did not have the dystrophic morphology seen after axotomy at 72 hrs PI (arrow). Error 
bars are representative of standard error margins and P values<0.05 are considered 
significant (indicated by*). Scale bars, A,B,C 50µm; E, 15µm. 
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Figure 6.2 Axonal stretch injury induced localized highly motile filopodia-like 
sprouting. Video stills from live imaging of a Dil labeled stretch-injured axon bundle at 
48 hrs PI (Refer to supplementary video 3). A, Axonal stretch injury induced the 
formation of highly motile filopodial sprouts (arrows) at 48 hrs Pl. B, To increase clarity 
the video stills were adjusted using the shadows filter from Image J (NIH) software. 
Scale bar, 25 µm. 

Figure 6.3 Injury-induced axonal sprouts do not have classical growth cone structures 
but express growth associated protein- GAP43. A,B, C, Stretch injured axon bundles 
exhibit filopodial-like sprouts at 48 hrs PI (B, arrows). D,E, Scanning electron 
micrograph of filopodial sprouts (arrow) at 48 hrs PI. F, Immunolabelling for GAP43 
(red) and staining for F-actin (green) in an uninjured axon bundle. G, There was an 
accumulation of GAP43 (arrows) along the injured axon shaft at 48 hrs PI. H, Real-time 
PCR determined that there was an increase in GAP43 mRNA expression in stretch-
injured axons compared to uninjured controls. Error bars are representative of standard 
error margins. Scale bars, 25µm (A-C, F,G). 

at the site of maximal stretch (Fig. 6.3B). These sprouts did not _have the classical 'fan 
shaped' growth cone morphology (Fig. 6.3D&E) commonly seen in development 
(Chuckowree and Vickers, 2003). At 72 hrs PI, 65% of the stretch-injured axons had 
progressed to secondary axotomy and significantly less (13%) filopodial sprouts were 
observed. The loss of filopodial sprouts at 72 hrs PI was not associated with the formation 
of new axonal branches. 
Immunocytochemical labelling of the injured axon bundles, at 48 hrs PI, demonstrated an 
increased immunoreactivity for GAP43 (Fig. 6.3G) within the frayed region of the axon 
bundle. Specifically, increased GAP43 immunoreactivity was associated with the periphery 
of the stretch injured axon bundle. No alterations or increases in GAP43 immunoreactivity 
were seen in the uninjured control axon bundles at any time point (Fig. 6.3F). Real-time 
PCR studies also demonstrated a significantly (P<0.05) increased expression of GAP43 in 
stretch injured cultures at 48 hrs PI (Fig. 6.3H). 
6.3.4 Inhibition of calcineurin and actin polymerisation 
Calcium/calmodulin-dependant kinase II and calcineurin are important regulators of axon 
collateral growth (Wen et al., 2004). FK506, a potent inhibitor of calcineurin (Bavetta et al., 
1999), was utilized to determine whether post-injury axonal sprout formation is modulated 
by calcium signalling pathways. Pre-injury treatment of stretch injured axons with FK506 
resulted in increased length of axonal sprouts (>50µm) at 48 hrs PI (Fig. 6.4). 
Actin dynamics play an important role in the formation of collateral filopodial sprouts 
(Gallo and Letourneau, 1998) and initial growth cone behaviour and neurite development 
(Dent and Kalil, 2001). In this study, lµg/ml latrunculin-A, an inhibitor of actin 
polymerisation, added to cultures prior to axonal stretch injury, significantly (P<0.05) 
inhibited filopodial sprout formation following injury (Fig. 6.5). 
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Figure 6.4 Calcineurin inhibition was associated with increased axonal sprout length 
following stretch injury. A,B, Stretch-injured axon bundles (48 hrs PI), pretreated with 
0.5µM FK506 and immunolabelled for phosphorylated neurofilaments (A, SMI312) and 
stained for F-actin (B). FK506 results in increased numbers of sprouts (A, arrows, inset: 
additional treated stretch-injured axon bundle) and filopodial length (arrows) at 48 hrs 
PI. Scale bar, 50µm. 

Figure 6.5 Inhibition of actin polymerization with latrunculin-A abolished post axonal 
stretch injury sprouting. A,B Stretch-injured axon bundles treated with 1 µg/ml 
latrunculin-A, an inhibitor of actin polymerization, did not exhibit axonal sprouts at 48 
hrs PI as demonstrated by immunolabelling for phosphorylated neurofilament (SMI312) 
and staining for F-actin (For reference, insets in A and B are of additional separate 
injured axon bundles). In addition, few latrunculin-treated axon bundles displayed the 
'frayed' morphology at regions of maximal strain (arrows) as seen in time-matched 
untreated control preparations. C, Graph indicates the percentage of treated and 
untreated axon bundles with filopodial sprout formation. Pre-injury latrunculin-A 
treatment of stretch injured axons significantly (P<0.05) reduces axonal sprouting at 48 
and 72 hrs PI. Scale bar, SOµm. 
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6.4 DISCUSSION 
In this chapter, the regenerative capacity of stretch injured axons was assessed. At 48 hrs 
PI, stretch injured axon bundles display a 'frayed' morphology with NF immunolabelling 
(chapter 3) (Fig. 6.IB) as well as focal axonal swelling. Live imaging of the swollen and 
frayed regions of the injured axon bundle demonstrated highly motile filopodia-like sprout 
protrusions at this time-point. These filopodial protrusions bear close resemblance to the 
fine sprouts emerging from bulbous, reactive axons some hours following direct transection 
(Dickson et al., 2007). Similarly, significant cytoskeletal reorganization also observed 
following stretch injury (Chapters 3 and 4; Fig. 6.1), including MT debundling, underlies 
the formation of collateral axonal sprouts in cultured spinal sensory neurons induced by 
contact with beads coated with growth factors (Gallo and Letourneau, 1998). Likewise, 
Ozaki and Snider ( 1997) have also reported that peripheral sensory axon collateral 
fo~ation in the developing spinal cord is preceded by a localized swelling of the axon. 
These data combined with the current study indicate that sprout formation may follow 
localised disruption of normal cytoskeletal arrangements and axonal swelling. 
During development and following axon transection, de novo axon collateral branches are 
guided by growth cone structures (Castellani et al., 1998; Chuckowree and Vickers, 2003), 
which contain the growth-associated protein GAP43 (Avwenagha et al., 2003). In this 
chapter, scanning electron microscopy illustrated that the fine protrusions that resembled 
extended filopodia, evident at 48 hrs PI, did not have the classical 'fan shaped' growth cone 
morphology (Fig. 6.3D&E) commonly seen in development (Chuckowree and Vickers, 
2003). Furthermore, these motile sprouts failed to develop into axonal branches, suggesting 
that this injury-induced regenerative sprouting response is deficient. In this regard, the lack 
of growth cone structures may underlie this abortive sprouting response. This is further 
supported by previous studies, both in vitro and in vivo, that show that axon transection in 
mature neurons results in aberrant sprouting. For example, regenerative sprouts following 
axonal transection in vitro have 'club-like' endings, rather than classic growth cones, which 
may contribute to an impaired regenerative capacity (King et al., 2001; Chuckowree and 
Vickers, 2003). Furthermore, axonal sprouting following direct neurite damage lacks 
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directionality and is unresponsive to a number of growth factors (Blizzard et al., 2007). The 
lack of growth guidance structures in this study may suggest that the post injury axonal 
sprouting response is primarily regulated by intrinsic cellular changes that may be related to 
cytoskeletal de-stabilization and re-organization precipitated by stretch injury. 
Pre-injury treatment of stretch injured axons with FK506, a calcineurin inhibitor, resulted 
in an increased length of axonal sprouts. FK506 has been shown to promote neurite 
outgrowth in cultures of PC12 cells, sensory ganglia, and developing dopamine neurons in 
vitro (Lyons et al., 1994; Costantini and Isacson, 2000). FK506 acts by binding to receptor 
proteins, FK506-binding proteins, which in tum regulate a calcium-dependent phosphatase, 
calcineurin, and a calcium release channel, the ryanodine receptor (Lyons et al., 1994). 
Interestingly, in experimental models, levels of FK506-binding proteins during neural 
regeneration parallel those of growth-associated protein GAP43, which is also a calcineurin 
substrate (Lyons et al., 1994). Stretch injury of primary rat cortical axons induces 
proteolytic cleavage of the voltage-gated sodium channels resulting in increased 
intracellular calcium (Iwata et al., 2004), which may lead to activation of calcineurin. 
Treatment of injured axons with tetrodotoxin prevented this calcium influx (Iwata et al., 
2004), and may also prevent calcium transients in developing neurons leading to inhibition 
of collateral sprouting (Hutchins and Kalil, 2008). The specific growth promoting effects of 
FK506 remains unclear. In developing dopaminergic neurons, FK506 induced elongation, 
but not axonal branching, and was similar to the effect of glial-derived neurotrophic factor 
(GDNF) (Costantini et al., 2000). Previous studies have suggested that inhibition of 
calcineurin increases the phosphorylation of GAP43, which is mandatory for axon 
regeneration (Rosenstiel et al., 2003). The FK506-mediated increase in GAP43 following 
axotomy to rat retinal ganglion cells and the optic nerve may reflect an increased 
regenerative potency of this compound (Rosentstiel et al., 2003). Additionally, this may 
also explain the improved axonal sprouting response following administration of FK506, 
illustrated in this study. 
Pre-injury application of latrunculin-A, an inhibitor of actin polymerisation, abolished the 
formation of axonal sprouts. During development, axon branching is modulated by 
81 
interactions between MTs and actin filaments (Dent and Kalil, 2001). In growth cones and 
at axon branch points, splaying of looped or bundled MTs is accompanied by focal 
accumulation of F-actin (Dent et al., 1999; Kalil et al., 2000). The pharmacological 
inhibition of actin polymerisation with cytochalasin D blocked collateral filopodial sprout 
formation in developing axons (Gallo and Letourneau, 1998). Further studies have shown 
that inhibition of F-actin dynamics prevents axon branching but not axon elongation (Dent 
and Kalil, 2001). Similarly, the current results indicate that actin dynamics play an 
important role in driving the post-injury filopodial sprouting. 
In summary, mild to moderate acute axonal stretch injury induces localized delayed 
filopodial activity, closely resembling that which is known to precede collateral branch 
formation in developmental models. These fine protrusions resembled extended filopodia 
more than genuine axonal branches, and contained growth associated proteins. However, 
these induced neuritic sprouts lacked the necessary growth guidance structures associated 
with initial neurite development, such as authentic growth cone structure and behaviour. 
Additionally, calcium signalling pathways and actin dynamics had a role in the formation 
of these axonal sprouts. These data indicate that damaged axons respond in a dynamic 
fashion to focal axon perturbation, and may provide insight into abnormal axonal sprouting 
that has been linked to post-traumatic epileptiform activity. 
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7 GENERAL DISCUSSION 
Traumatic brain injury evokes widespread DAI, which significantly contributes to both 
morbidity and mortality (Povlishock et al., 1992; Smith et al., 2003; Povlishock and Katz, 
2005; Buki and Povlishock, 2006). Although initial reports suggested instantaneous axon 
severance at the moment of injury, many studies have not supported this premise (Buki and 
Povlishock, 2006). Rather, the majority of studies have illustrated the evolving 
pathogenesis of DAI, which results in progressive neuronal alterations ultimately leading to 
secondary axotomy and degeneration. This thesis has utilised a novel in vitro axonal stretch 
injury model, which leads to pathological alterations associated with DAI, to investigate the 
cellular and molecular mechanisms initiating and contributing to the delayed degeneration 
of injured neurons. 
The in vitro axonal stretch injury model developed in this thesis utilises a well-defined 
primary cortical cell culture protocol (Dickson et al., 2000; Chuckowree and Vickers, 2003; 
Haas et al., 2004; Blizzard et al., 2007). This protocol involves the long-term culturing of 
rat embryonic cortical neurons until relative maturity, and is characterised by the presence 
of discrete and suspended axonal bundles between cell body clusters (Dickson et al., 2005). 
These axon bundles are injured using a brief (20 psi over 13-20 msec) fluid pressure pulse, 
which causes the axonal bundles to rapidly stretch and twist, before returning to its original 
orientation. Importantly, this form of stretch injury does not cause primary axotomy and is 
a relatively mild form of injury. 
7.1 AXONAL STRETCH INJURY AND THE NEURONAL CYTOSKELETON 
Consistent with other models of DAI (Graham et al., 2000; Stone et al., 2001; Lifshitz et 
al., 2003; Marmarou et al., 2005), this thesis illustrates that mechanical trauma to axons 
induces a multi-faceted, heterogeneous, response. This is highlighted by the altered NF 
response to stretch injury, which was shown in some cases to precede secondary axotomy 
(Fig 7.1). In this regard, stretch injured axons demonstrated either increased SMl312 (labels 
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Figure 7.1 Post-injury sequelae involves progressive cytoskeletal disrup-
tion ultimately resulting in secondary axotomy at 72 hrs PI (MTs in blue 
and NFs in black). Axonal swellings are evident at 48 hrs PI and may be 
due to calcium induced cytoskeletal degradation. Additionally, NF can 
occur in a subpopulation of stretch injured axons (B). 
in segregated and undulated NF fibers localized to regions of axonal swellings. Increased 
SMI312 immunoreactivity, indicative of NF compaction, occurred early in the post-injury 
sequelae, first evident at 24 hrs PI and maximal at 48 hrs Pl. A similar heterogenous 
response was illustrated following impact acceleration injury in rats (Stone et al., 2001). 
Using double-labelling immunocytochemical techniques, Stone and colleagues further 
illustrated that NF compaction occurs earlier and is independent of altered axonal transport. 
Interestingly, it is also possible that this increased SMI312 immunoreactivity reflects an 
alteration in phosphorylation state of some of the NFs present within the injured axon. 
Indeed, changes in the phosphorylation state of the NF side-arms have long been associated 
with NF compaction (Povlishock, 1993). The results presented in this thesis also indicate a 
significant loss of injured axons with NF compaction at 72 hrs Pl. It is unclear whether 
these injured axons have progressed to secondary axotomy. Recent electron microscopy 
studies have reported significant axonal recovery from NF compaction following brain 
trauma in rats (Gallyas et al., 2006). Conversely, non-recovering compacted axons 
progressed to secondary axotomy via a non-Wallerian form of degeneration, which is 
mostly reversible (Gallyas et al., 2006). 
Stretch-injured axon bundles with abnormal rearrangements of NF structure were typically 
evident at later time-points in comparison to NF compaction. Immunocytochemical 
labelling of these injured axons in chapter 3 demonstrated that this cytoskeletal disruption 
is localized to regions of axonal swelling. Furthermore, these regions were the sites of 
secondary axotomy at 72 hrs Pl. Similar cytoskeletal abnormalities have been reported 
following in viva mechanical head trauma, with NFs withdrawing from the axolemma to 
display an abnormal alignment oblique to the longitudinal axis of the axon (Povlishock, 
1992, Yaghmai and Povlishock, 1992; Fitzpatrick et al., 1998). Additionally, ,these NF 
alterations also became worse over time and were followed by axonal expansion and the 
accumulation of organelles (Fitzpatrick et al., 1998). This sequence of events, with a 
distinct progression of NF alterations, was also observed ii) of the CNS brain from fatally 
injured individuals (Grady et al., 1993; Christman et al., 1994). Altogether, this thesis 
illustrates that following mechanical trauma axons do not respond in a stereotypical 
manner, rather variable degrees of shear/strain initiate different responses. In this regard, 
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NF disruption, particularly resulting in the formation of axonal swellings, plays an 
important role in the eventual progression to secondary axotomy. 
7.2 AXOLEMMA PERMEABILITY ALTERATIONS 
Previous studies have focused on the direct consequences of shear and stretch forces on 
axolemma permeability. Early studies reported focal microscopic mechanoporation of the 
axolemma, reflected in the influx of normally excluded tracers such as horse-radish 
peroxidase (Pettus and Povlishock, 1996). The potential consequence of this 
mechanoporation is the detrimental influx of calcium, which has been linked to the 
degradation of the cytoskeleton via activation of proteases and phosphatases. However, less 
severe, non-severing, models of axonal injury such as presented in this thesis do not 
provide evidence of immediate axolemma permeability alterations. Results from a similar 
in vitro axon stretch injury model support this finding with altered permeability only seen 
following primary axotomy (Smith et al., 1999). Importantly, the results from this thesis 
demonstrate delayed alterations to axolemma permeability associated with cytoskeletal 
damage. It is clear from other studies involving axonal stretch injury that increased 
intracellular calcium plays an important role in the degradation of the axon cytoskeleton as 
seen by the calcium mediated activation of calpains and caspases (Saatman et al., 2003; 
Serbest et al., 2007). Accordingly, cytochrome-C release from mitochondrial stores has also 
been illustrated in this study and is reported to be induced by increased intracellular 
transients (Buki et al., 1999). In similar stretch injury models, this increase in intracellular 
calcium is reported to be due to altered activation of Na+ channels, with the demonstration 
that the subsequent axonal depolymerisation triggers the activation of voltage sensitive Ca2+ 
channels (Iwata et al., 2004). Further studies illustrated limited or no increase in 
intracellular calcium when stretch injuries were conducted in calcium free media, which 
suggests calcium dysregulation is due to influx of extracellular calcium. In this thesis, 
axonal stretch injury resulted in two distinct intracellular calcium increases. The 
thapsigargin-mediated release of calcium from endoplasmic stores induces a similar 
calcium flux profile as seen following stretch injury. Interestingly, axonal stretch injury in 
calcium-free ACSF resulted in only a single peak increase in intracellular calcium. Indeed, 
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this single peak increase in intracellular calcium was similar in magnitude and temporal 
profile to the initial calcium flux observed in both injuries conducted in calcium-containing 
ACSF and following thapsigargin-mediated release of calcium from endoplasmic stores. 
Thus, these results support the possibility that the initial peak increase in intracellular 
calcium following stretch injury is due to release from intracellular stores. The second peak 
calcium influx following stretch injury may be due to influx from extracellular stores as 
this intracellular calcium increase is abolished in calcium-free ACSF. Traumatic injury of 
cortical neurons has been shown to alter intracellular calcium stores, which is linked to 
subsequent capacitative (store-operated) calcium influx (Weber et al., 2001). Additionally, 
this calcium induced extracellular calcium entry has been reported following ischemic 
spinal cord white matter damage (Ouardouz et al., 2003). Other studies have illustrated the 
pathological influx of calcium through activated Na-channels, which may be an ideal 
candidate for further investigation as a possible mechanism associated with the secondary 
peak increase in intracellular calcium (Wolf et al., 2001; 2005). The results from this study 
suggest that both the release of calcium from intracellular stores and the subsequent influx 
of extracellular calcium play an important role in the post-traumatic increase in intracellular 
calcium (Fig 7.2). 
Calcium-mediated proteolysis of Na- channels has been associated with the progressive and 
sustained increase in intracellular calcium levels in more severely stretch injured axons 
(Iwata et al., 2004). Additionally, pre-injury and post-injury inhibition of calcium-activated 
proteases attenuated long-term increases in intracellular calcium as well as mitigating 
degradation of the sodium channels (Iwata et al., 2004). In summary, the immediate 
increase in intracellular calcium may activate proteases which in-tum progressively 
degrades Na-channels resulting in a unique "feed-forward" process, perpetuating 
pathological calcium influx. This influx of calcium over the post-injury period may result 
in the activation of apoptotic mechanisms and cytoskeletal degradation, which will be 
discussed further later in this chapter. 
7.3 MITOCHONDRIAL DYSFUNCTION 
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Mitochondrial dysfunction is closely associated with DAI following head trauma (Buki et 
al., 1999, 2000; Arnoult et al., 2002). The· consequence of increased intracellular calcium, 
as described above, is the evoked calcium-induced opening of the MPT pore (Hirsch et al., 
1998; Arnoult et al., 2002). The current study illustrates the release and accumulation of 
cytochrome-C into the cytoplasm within axon swellings. The release of cytochrome-C is 
indicative of the opening of the MPT pore, which also results in the release and activation 
of different members of the caspase enzyme family (Mancini et al., 1998; Krajewski et al., 
1999; Susin et al., 1999). Although the release of cytochrome-C could be illustrated with 
co-localisation immunulabelling with mitochondrial markers and cytochrome-C, it is not 
clear whether there is further mitochondrial damage concomitant with the opening of the 
MPT, which include mitochondrial swelling due to uptake of water (Hirsch et al., 1998; 
Buki and Povlishock, 2006). The mitochondrial injury in itself is detrimental to the viability 
of the neuron as it provides a serious energetic/homeostatic challenge. In this study, the 
release and accumulation of cytochrome-C was localised to the site of maximal cytoskeletal 
damage and associated with the eventual loci of axotomy. Similar studies involving in viva 
rat brain injury models have also supported this finding by illustrating that the foci of 
cytochrome-C release is localised to regions of calpain-mediated spectrin proteolysis (Buki 
et al., 1999, 2000). Other immunocytochemical studies have further demonstrated that 
caspase-3 activation and spectrin breakdown product, is also consistently co-localised with 
cytochrome-C and calpain mediated spectrin proteolysis (Buki et al., 2000; Farkas et al., 
2005; Buki and Povlishock, 2006; Serbest et al., 2007). These results, including evidence of 
calpain mediated spectrin proteolysis leading to the collapse of the subaxolemmal 
membrane cytoskeleton, support this thesis findings of cytoskeletal damage associated with 
cytochrome-C release and delayed permeability alterations (Wang et al., 1998; Buki and 
Povlishock, 2006). However it is not clear whether both caspases and calpains are 
associated with the full spectrum of post-injury sequelae or just the later sequence of events 
immediately prior to secondary axotomy. Current reports, including the results of this 
study, tend to demonstrate cytochrome-C release at later stages of the post-injury sequelae, 
typically associated with mitochondrial damage (Buki and Povlishock, 2006). Accordingly, 
in this thesis, cytoskeletal damage is occurred prior to, and in some circumstances, 
independent to, axonal swellings and cytochrome-C release. This may indicate that other 
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cytoskeletal degradative pathways are initiated, particularly at the earlier stages of the post-
injury sequelae. Indeed, in this thesis, inhibition of calcineurin with FK 506, which does 
not inhibit the MPT pore and release of cytochrome-C as with cyclosporin-A, resulted in an 
attenuation of cytoskeletal damage and secondary axotomy. These results provide further 
evidence that cyclosporin-A's therapeutic effect may principally be due to calcineurin 
activity rather than inhibition of the MPT pore. This is further supported by other in viva rat 
brain injury studies that demonstrated attenuation of impaired axonal transport and 
cytoskeletal damage resulting in improved neuronal survival following administration of 
FK 506 (Mannarou and Povlishock, 2005; Reeves et al., 2007). However, these studies in 
conjunction with the results of this thesis suggest that FK 506 does not attenuate the full 
spectrum of cytoskeletal damage, specifically, NF compaction. 
7.4 CALCINEURIN ACTIVITY 
Calcineurin, a calcium/calmodulin-dependant protein phosphatase, 1s known to 
dephosphorylate a number of substrates including the cytoskeleton (Morioka et al., 1998). 
Due to the diversity of substrates dephosphorylated by calcineurin, FK 506 may exert a 
neuroprotective effect via multiple pathways. In addition to modulating the phosphorylation 
state of cytoskeletal proteins resulting in abnormal reorganisation, calcineurin may also 
operate on other cellular targets involved in the axonal response to injury. The drug FK 506 
binds to FK 506 binding protein-12, an integral part of the IP3 and ryanodine receptor 
complexes, and appears to alter cytosolic calcium released through these channels 
(Brillantes et al., 1994; Cameron et al., 1995; Reeves et al., 2007). This calcineurin-
modulated calcium release may further be involved with the later activation of calcium-
modulated degradative cascades. As discussed above and illustrated by this thesis, 
inhibition of calcineurin attenuates cytoskeletal damage commonly associated with 
activation of caspases and calpains (Marmarou and Povlishock, 2005; Reeves et al., 2007). 
This suggests the initial activity of calcineurin is linked to the activation of these calcium-
modulated proteases. In this regard, the subtle calcium alterations, linked primarily to 
release from internal calcium stores, may only be adequate to trigger high-affinity calcium-
calmodulin targets such as calcineurin, which require only nanomolar concentrations 
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(Shields et al., 1997; Stys and Jiang, 2002;). This would preclude calpains, as activity of 
this enzyme is dependant on millimolar calcium concentrations (Marmarou et al., 2006). 
Further and persistent calcium dysregulation demonstrated later in the post-injury sequelae 
might be associated with the activation of calpain and caspases. However, as shown in this 
study, inhibition of calcineurin with FK 506 did not attenuate NF compaction. 
There are emerging studies that demonstrate increased levels of NFM phosphorylation 
following inhibition of calcineurin (Piumelli et al., 2008). This thesis illustrated increased 
NP phosphorylation following axonal stretch injury, which was also associated with NF 
compaction. Indeed, alterations in NP phosphorylation would be expected to alter NF-side 
arm interactions resulting in compaction (Okonkwo et al., 1998). As previously discussed 
(section 7.1), much controversy remains on the mechanisms underlying NP compaction, 
however, it is clear that NF compaction occurs at the earliest stages of the post-injury 
sequelae and in human TBI cases remains stable for at least up to six hours (Maxwell et al., 
1997; Jafari et al., 1998;). It remains to be determined whether NP compaction confers 
neuronal death exhibited by secondary axotomy. As discussed, a significant number of 
injured neurons can recover from NP compaction in the axon, conversely, a subset of 
neurons progressed to secondary axotomy via a mostly reversible non-Wallerian form of 
degeneration (Gallyas et al., 2006). Interestingly, phosphorylation of NFH reduces the rate 
and extent of proteolysis by calpain (Greenwood et al., 1993), and preferential proteolysis 
of dephosphorylated compared to phosphorylated NPH has been shown in spinal cord 
injuries (Schumacher et al., 1999). This may suggest that phosphorylation of NP's, which is 
increased following injury and inhibition of calcineurin, results reduced proteolysis by 
calpains and NF compaction. The spontaneous recovery of NP compacted axons may 
explain in humans one of the causes leading to the eventual improvement of physical and 
mental capabilities, that were lost at the moment of injury (Gallyas et al., 2006). In 
summary, this thesis highlights the multiple cytoskeletal initiated by calcium dysregulation. 
In regard to mild to moderate axonal trauma, which results in immediate subtle calcium 
dysregulation without overt axolemma alterations, the high affinity calcium/calmodulin 
targets such as calcineurin may be the initial modulator of eventual cytoskeletal damage. 
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7.5 UPS INVOVLEMENT FOLLOWING AXONAL INJURY 
The delayed accumulation of Ub within axonal swellings was associated with the release 
and accumulation of cytochrome-C. The accumulation of Ub within axon swellings has 
also been illustrated using the fluid percussion model of closed head injury in the cat 
(Schweitzer et al., 1993). As seen in this thesis, the rapid accumulation of Ub 
immunoreactivity is linked to alterations in NP structure (Schweitzer et al., 1993). 
Furthermore, the accumulation of Ub conjugates and inclusion bodies as long been 
illustrated in lesions associated with many chronic neurodegenerative diseases, including 
the neurofibrillary tangles of Alzheimer's disease, Lewy bodies in Parkinson's disease and 
recently in other neurological syndromes including gracile axonal dystrophy (Alves-
Rodrigues et al., 1998; Saigoh et al., 1999; Glickman and Ciechanover, 2002). Inhibition of 
the UPS, with MG132 and lactacystin, profoundly delayed degeneration following in vitro 
axon transection of cortical neurons (Zhai et al., 2003). The pre-injury administration of 
these protease inhibitors in this study's in vitro model of axonal injury, however, 
accelerated the progression to secondary axotomy. These results suggested the involvement 
of ubiquitination in the survival of injured axons following stretch injury. It is important too 
note that axonal stretch injury and axon transection, may initiate different mechanisms of 
axonal degeneration. Indeed, axon transection typically results in the delayed Wallerian 
degeneration (Zhai et al., 2003). In this regard, UPS involvement in Wallerian degeneration 
is proposed to be detrimental to the survival of the transected neuron (Wang et al., 2001; 
Ehlers, 2004). In contrast, few studies have investigated the role of the UPS in a non-
transectional model of axonal injury. As a result, the UPS has been implicated as having a 
similar, pathological, role in both injury paradigms. However, early studies reporting a rise 
in cytoplasmic ubiquitin levels following nerve crush injury, have suggested Uh-mediated 
degradation of damaged proteins in peripheral motor neurons favouring survival of the 
damaged neuron (Shyne-Athwal, 1986; Savedia and Kierman, 1994; Wang and Ingoglia, 
1997; De Stefano et al., 1998). Following axonal stretch injury, it is possible that the UPS 
is involved in the degradation of products from calpain-mediated cytoskeletal damage 
(Ehlers, 2004). This is supported by evidence of increased ubiquitin immunoreactivity 
localized to regions of cytochrome-C release and maximal cytoskeletal degradation. 
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Accordingly, calpain inhibitors have also been found to delay axon degeneration following 
axon transection (Raghupathi, 2004). Interestingly, removal of extracellular calcium, using 
EGTA, also delayed axonal degeneration following transection, suggesting an upstream 
calcium-dependant signalling event. As calcium dysregulation resulting in caspase and 
calpain activation is illustrated following axonal stretch injury (Iwata et al., 2004; 
Raghupathi, 2004), it is possible that these events could also involve activation of the UPS 
pathway (Ehlers, 2004). Altogether, these results suggest that alternative techniques aimed 
at improving UPS function following axonal injury, may be a more effective therapeutic 
strategy opposed to inhibition of the UPS itself. 
7.6 AXONAL SPROUTING 
Axonal sprouting following axon transection and during development has been studied 
extensively (Chuckowree and Vickers, 2003; Dent et al., 2004; Hagg, 2006; Blizzard et al., 
2007). There is increasing data that suggest that following mild to moderate TBI, diffuse 
deafferentation sets the stage for the sprouting of adjacent intact nerve fibres that, in many 
cases, results in significant recovery of synaptic input to the previously deafferented 
neuronal domains (Erb and Povlishock, 1991; Povlishock and Katz, 2005; Hagg, 2006). 
This thesis illustrates that axonal stretch injury induces sprouting of filopodial-like 
processes along the injured axon shaft. These highly motile processes resemble that which 
is seen prior to collateral branch formation during development. Specifically, collateral 
branches are initiated by the appearance of localized filopodial activity along previously 
quiescent axonal shafts (Gallo and Letourneau, 1998). This rapid sprouting of filopodia is 
induced in sensory neurons at sites of contact with nerve growth-factor coated polystyrene 
beads (Gallo and Letourneau, 1999). These axonal sprouts, induced. by stretch injury, do 
not continue to form new axonal branches in this in vitro model and this may be due to the 
lack of classical growth guidance structures illustrated during development (Chuckowree 
and Vickers, 2003; Blizzard et al., 2007). Abnormal growth guidance structures are also 
implicated in the deficient regenerative response following axon transection (Blizzard et al., 
2007). The axonal sprouting response illustrated in this thesis is modulated by actin 
dynamics, which is also demonstrated to play a crucial role in the development of collateral 
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branches in uninjured neurons (Dent and Kalil, 2001). There may also be similarities in the 
mechanisms initiating this axonal sprouting response. Recent studies of collateral 
sprouting, suggest that transient intracellular calcium increases may play a pivotal role in 
the protrusion of axon branches in cortical neurons (Tang and Kalil, 2005). The release of 
calcium from intracellular stores, as demonstrated following axonal stretch injury, is 
implicated as a source for these calcium transients (Tang and Kalil, 2005). Interestingly, 
calcium/calmodulin-dependent pathways, which are also initiated following stretch injury, 
also modulate axonal branching during development. 
There are few studies that have investigated the regenerative sprouting response of mild to 
moderately injured axons. Indeed, further investigation is required as axonal sprouting 
following injury may be indicative of an adaptive mechanism for functional recovery after 
injury, or maladaptive, playing a pivotal role in the generation of epileptiform events due to 
increased numbers of synaptic contacts between neurons (Hagg, 2006). It is generally 
accepted that following more severe forms of axonal injury, there is maladaptive change 
due to inappropriate fibre ingrowth and/or cytoarchitecture modification (Phillips et al., 
1994, 2001; Povlishock and Katz, 2005). In this regard, the inappropriate fibre ingrowth is 
proposed to originate from severed axons as this sprouting response has been well 
characterised in vitro (Chuckowree and Vickers, 2003). This, however, has not been proved 
and there is possibility that these inappropriate fibres may be originating from injured, but 
not severed, axons as demonstrated in this thesis. Axon compression has been illustrated to 
induce axonal sprouting following end-to-side neurorrhaphy (Hayashi et al., 2008). 
Although this study is based in the PNS it highlights some interesting caveats. Extrinsic 
nerve compression can increase small diameter unmyelinated axon counts, hence, it is 
possible that the axonal sprouting response is from unmyelinated sensory axons 
(Mackinnon et al., 1986; Hayashi et al., 2008). Only recently has it become evident that 
TBI results in damage to multiple fibre populations including large and fine-calibre 
myelinated and non-neuropathologically detected unmyelinated fibres. The stretch injured 
axons in this study are unmyelinated, and there is evidence of increased susceptibility of 
these axons to TBI, which may significantly contribute to the ensuing morbidity (Reeves et 
al., 2005; Povlishock and Katz, 2005). It is not inconceivable that reactive axonal sprouting 
92 
may be from unmyelinated axons, given the growth inhibitory nature of myelin (Wang et 
al., 2001). In summary, intracellular calcium dysregulation induced by stretch injury may 
trigger axonal sprouting via activation of calcium/calmodulin dependant pathways. These 
aberrant sprouts contain growth-associated proteins, however, lack guidance structures, 
which may result in inappropriate synaptic formation in viva. 
In summary, an advantage of the in vitro model presented in the thesis, is that it reliably 
reproduces the evolving axonopathy, characteristic of human DAI, over an extended period 
of time. Thus, it provides an ideal experimental platform to investigate important 
mechanistic insights into the underlying cause of DAI, and also examine novel therapeutic 
approaches. However, this novel model of axonal stretch injury involves injury to axonal 
bundles and not single neurites. Another reservation is that the injured axon bundles in this 
thesis are unmyelinated. Additionally, as only a small population of neurons in culture are 
injured, opposed to a broad injury to the majority of cultured neurons, it is often difficult to 
utilise current proteomic techniques. In this regard, the results from this experimental 
model of stretch injury provide only part of the complex post-DAI response and needs to be 
addressed in conjunction with other in vitro axonal stretch injury models, so as to provide a 
more clinically relevant understanding. Indeed, in vitro models of brain injuries are not 
capable of surpassing in viva models, but they are able to complement them, and permit the 
exploration of different aspects of head trauma including insights into the mechanism of 
cellular change that leads to axonopathy. 
7.7 CONCLUSIONS 
• We present a simple, reproducible model of axonal stretch injury that results 
in progressive cytoskeletal alterations and secondary axotomy, characteristic of 
DAI. 
• Axons do not respond in a stereotypical manner to a transient stretch insult, 
and indeed that variable degrees of stretch injury activate diverse responses 
within axons, with dramatically different outcomes. 
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• Axonal stretch injury does not result in overt mechanoporation of the 
axolemma, rather, injury induces intracellular calcium dysregulation due to 
release of calcium from intracellular stores. 
• There is the delayed release and accumulation of ubiquitin and pro-apoptotic 
cytochrome-C within axon swellings, which is associated with maximal 
cytoskeletal damage. 
• Inhibition of calcineurin with FK506 attenuates cytoskeletal damage and 
secondary axotomy following injury. 
• Inhibition of the UPS accelerates the axonal progression to secondary axotomy. 
• Axonal stretch injury induces axonal sprouting. Axonal sprouts contain growth 
proteins, however, lack guidance structures. 
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9 SUPPLEMENTARY MOVIES 
Supplementary movie 1At21 days in vitro, an individual bundle of axons were targeted 
with a single pulse of fluid, and the resultant deflection was captured by video camera. In 
this movie, the axon bundle is rapidly stretched, before recovering to its original position. 
For reference, the maximal increase in original axon length of this bundle caused by the 
deflection was 3%. 
Supplementary movie 2 Following three-dimensional reconstruction of images captured 
through the entire axon bundle, the compiled stack was sequentially rotated in 1° intervals 
in the x-axis and combined into a QuickTime™ movie to allow accurate 3-D spatial 
representation of immunocytochemically-labelled cytoskeletal neurofilament protein 
features within the injured axon bundle. 
Supplementary movie 3 Live-imaging of an injured mature cortical neuron at 48 hrs Pl. 
The neuron is loaded with Dil prior to imaging. Frames were captured at 1 frame/3 
seconds. 
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10 APPENDIX - SOLUTIONS 
10.1 GENERAL SOLUTIONS 
All solutions were made up in Milli-Q® water, unless otherwise stated. 
O.OlM phosphate buffered saline (PBS), pH 7 .4 
• lOOml NaCl - 90g/L stock solution 
• 40ml di-sodium hydrogen orthophosphate (Na2HP0412H20) - 28.4g/L stock solution 
• lOml sodium di-hydrogen orthophosphate (NaH2P04 .H20) - 31.2g/L stock solution 
• 850ml Milli-Q® water 
• pH 7.4 
4% paraformaldehyde (PFA) (lOOml) 
• 4g paraformaldehyde 
• 4g sucrose 
• lOml di-sodium hydrogen orthophosphate (NaH2P04.H20) - 31.2g/L stock solution 
• 40ml sodium di-hydrogen orthophosphate (NaH2P04) - 28.4g/L stock solution 
• 50ml Milli-Q® water 
• dissolve by heating (-80°C ) on stirrer hotplate in fume hood 
Borate buffer 
• 38.16g/L di-sodium tetraborate (Na2B40 7 .10H20) 
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• add disodium tetraborate solution to the boric acid solution until pH 7.4 is reached 
lOmM HEPES (N-2-hydroxyethyl piperazine-N-2 sulphonic acid) buffer 
• make up lOmM solution in O.OlM PBS (2.38g/L), filter sterilise before use 
Propridium iodide 
• 5mg propridium iodide 
• lOOmg sodium citrate 
• Dissolve in lOOml Milli-Q® water 
Imaging buffer (50ml) 
• 1.55ml NaCl - 234g/L stock solution 
• 250µ1 KCl- 149.2g/L stock solution 
• 5µ1 CaC12-294g/L stock solution 
• 25µ1 MgC12 -406.6g/L stock solution 
• 750µ1 Dextrose - 360.4g/L stock solution 
• 625µ1 HEPES - 520.6g/L stock solution 
Diluent 
• 0.3% Triton X-100 in O.OlM PBS 
O.lM Phosphate buffer 
• 216ml dibasic sodium phosphate (Na2HP042H20)-35.6g/L 
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• 84ml monobasic sodium phosphate (NaH2P042H20)-20.76g/L 
• 300ml Milli-Q® water 
• pH 7.4 
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Supplementary movie 1 At 21 days in vitro, an individual bundle of axons were targeted 
with a single pulse of fluid, and the resultant deflection was captured by video camera. 
In this movie, the axon bundle is rapidly stretched, before recovering to its original 
position. For reference, the maximal increase in original axon length of this bundle 
caused by the deflection was 3%. 
Supplementary movie 2 Following three-dimensional reconstruction of images captured 
through the entire axon bundle, the compiled stack was sequentially rotated in 1 ° 
intervals in the x-axis and combined into a QuickTime™ movie to allow accurate 3-D 
spatial representation of immunocytochemically-labelled cytoskeletal neurofilament 
protein features within the injured axon bundle. 
Supplementary movie 3 Live-imaging of an injured mature cortical neuron at 48 hrs Pl. 
The neuron is loaded with Dil prior to imaging. Frames were captured at 1 frame/3 
seconds. 
